capsule

SUNITCAP 12.5 MG Capsule (Sunitinib): Multi-Targeted Tyrosine Kinase Inhibition for Advanced Oncology SUNITCAP 12.5 MG Capsule is a sophisticated oral antineoplastic medication featuring the active pharmaceutical ingredient Sunitinib. As a powerful multi-targeted receptor tyrosine kinase (RTK) inhibitor, it is designed to disrupt the signaling pathways that tumors use to grow, divide, and develop a blood supply. Manufactured under stringent GMP quality standards, SUNITCAP 12.5 MG is a critical therapeutic intervention utilized globally to manage specific solid tumors that have become resistant to standard therapies. Therapeutic Indications and Global Clinical Usage Gastrointestinal Stromal Tumor (GIST): Indicated for the treatment of GIST after disease progression on or intolerance to imatinib mesylate. Advanced Renal Cell Carcinoma (RCC): Used as a primary or secondary treatment for advanced or metastatic kidney cancer. Pancreatic Neuroendocrine Tumors (pNET): Indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease. Mechanism of Action: How SUNITCAP 12.5 MG Works Inhibition of Angiogenesis: It blocks the Vascular Endothelial Growth Factor Receptors (VEGFR), which tumors use to grow new blood vessels to feed themselves. Proliferation Blockade: It targets Platelet-Derived Growth Factor Receptors (PDGFR) and other kinases (like KIT and FLT3), shutting down the “growth signals“ that tell cancer cells to multiply. Dual Action: By simultaneously starving the tumor of its blood supply and stopping cell division, SUNITCAP effectively induces tumor shrinkage and prevents further metastasis. Common Side Effects: Gastrointestinal: Diarrhea, nausea, vomiting, and altered taste (dysgeusia). Dermatological: Skin discoloration (yellowish tint), dry skin, and hand-foot syndrome (redness or swelling of palms/soles). Systemic: Fatigue, high blood pressure (hypertension), and mucosal inflammation. Hematological: Potential decrease in white blood cell or platelet counts. Professional Administration and Safety Protocols Route: Oral administration (capsule). Timing: Can be taken with or without food. Clinical Monitoring: Regular monitoring of blood pressure, heart function (LVEF), and thyroid function is mandatory during treatment. Precise Titration: The 12.5 mg strength is often used in a “4 weeks on, 2 weeks off“ schedule or continuous dosing, depending on the specific cancer type. Storage and Global Handling Instructions Storage: Store at controlled room temperature (20°C to 25°C). Packaging: Keep capsules in the original bottle to protect them from moisture and light. Why Choose Ernest Oncology? 100% Genuine Medication: Sourced directly from GMP-certified channels for maximum efficacy. Verified Global Export Network: We facilitate rapid and secure shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging to maintain product stability during transit. Regulatory Support: We handle all necessary export paperwork, including Certificates of Analysis (CoA), for seamless customs clearance. Bulk Supplier Advantage: Competitive wholesale rates to support oncology hospitals, specialized pharmacies, and government health departments. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: [exports@ernestpharmaceuticals.com] 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Lenvalieva 10mg Capsule: High-Potency Multi-Kinase Inhibition for Advanced Oncology Sourcing Are you searching for a verified Lenvalieva 10mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted therapies. We facilitate a secure, high-standard supply chain for London & the UK, the USA, Australia, and South Africa, ensuring that high-potency multi-kinase inhibitors reach oncology centers with 100% pharmaceutical integrity. Detailed Product Profile: What is Lenvalieva 10mg? Lenvalieva 10mg is an oral targeted therapy containing the active pharmaceutical ingredient Lenvatinib. Manufactured by Allieva, the 10mg capsule is a critical strength used in the management of several aggressive malignancies. As a potent kinase inhibitor, it works by interfering with the specific proteins that cancer cells use to grow, divide, and develop the blood vessels they need to survive. 1. Therapeutic Indications Differentiated Thyroid Cancer (DTC): For patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory DTC. Renal Cell Carcinoma (RCC): Used in combination with Everolimus for patients with advanced kidney cancer after one prior anti-angiogenic therapy. It is also a first-line option when combined with Pembrolizumab. Hepatocellular Carcinoma (HCC): As a first-line systemic therapy for patients with unresectable liver cancer. Endometrial Carcinoma: In combination with Pembrolizumab for advanced endometrial carcinoma that is not microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). 2. Mechanism of Action: Triple-Pathway Inhibition Anti-Angiogenesis: It blocks Vascular Endothelial Growth Factor Receptors (VEGFR1, 2, and 3). By preventing the formation of new blood vessels, it “starves“ the tumor of oxygen and nutrients. Blocking Fibroblast Signaling: It inhibits Fibroblast Growth Factor Receptors (FGFR1, 2, 3, and 4), which are often involved in tumor resistance to other therapies. Interrupting Growth Signals: It targets PDGFRα, KIT, and RET, halting the internal signaling pathways that tell cancer cells to multiply rapidly. 3. Administration and Dosage Usage: Taken once daily at the same time each day, with or without food. Dose Titration: The 10mg strength is vital for achieving higher daily dosages (such as 14mg, 18mg, 20mg, or 24mg) as required by specific clinical protocols for Thyroid or Renal cancer. Storage: Store at room temperature (below 30°C) in a dry place. Clinical Side Effects & Safety Monitoring Hypertension: High blood pressure is a frequent side effect; blood pressure must be optimized before starting therapy and monitored weekly. Gastrointestinal: Diarrhea, nausea, vomiting, decreased appetite, and weight loss. Fatigue: Significant tiredness or lack of energy is commonly reported. Dermatological: Palmar-plantar erythrodysesthesia (Hand-Foot Syndrome), characterized by redness, pain, or swelling on the palms and soles. Proteinuria: Potential for protein in the urine; regular urinalysis is recommended. Hepatotoxicity: Rare but serious liver damage; periodic liver function tests (LFTs) are mandatory. Cardiovascular Risks: Increased risk of arterial thromboembolic events (blood clots). Why Source Lenvalieva 10mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva’s Lenvalieva with full batch-specific traceability and COA. Logistics Authority: Expert handling of complex import regulations for London (UK), the USA, Australia, and South Africa. Bulk Supply Solutions: Competitive wholesale pricing for hospital groups, oncology networks, and regional distributors. Regulatory Compliance: Every shipment is accompanied by GMP certificates and complete B2B documentation to ensure the highest quality standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: Chat on WhatsApp

Enzalieva 40mg Capsule: Advanced Androgen Receptor Inhibition for Global Prostate Cancer Care Are you searching for a verified Enzalieva 40mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted therapies. We facilitate a secure, high-standard supply chain for London & the UK, the USA, Australia, and South Africa, ensuring that critical androgen receptor inhibitors reach oncology centers with 100% pharmaceutical integrity. Detailed Product Profile: What is Enzalieva 40mg? Enzalieva 40mg is an oral targeted therapy containing the active pharmaceutical ingredient Enzalutamide. Manufactured by Allieva, this 40mg capsule is a potent, non-steroidal androgen receptor inhibitor. It is a cornerstone treatment in modern uro-oncology, specifically designed to combat prostate cancer by blocking the hormones that fuel tumor growth, even when traditional hormone therapies have failed. 1. Therapeutic Indications Metastatic Castration-Resistant Prostate Cancer (mCRPC): For patients whose cancer has spread and no longer responds to surgical or medical treatments that lower testosterone. Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): For patients whose cancer has not spread but is at high risk of progressing despite androgen deprivation therapy. Metastatic Castration-Sensitive Prostate Cancer (mCSPC): Used in combination with androgen deprivation therapy for patients with metastatic disease that still responds to hormone suppression. 2. Mechanism of Action: The Triple-Blockade Strategy Binding Inhibition: It competitively inhibits the binding of androgens (like testosterone) to the androgen receptors within the prostate cancer cells. Nuclear Translocation Inhibition: It prevents the androgen receptor from moving into the cell nucleus, a critical step required for cancer cell signaling. DNA Binding Inhibition: Even if the receptor reaches the nucleus, Enzalieva prevents it from binding with DNA, effectively “turning off“ the genetic instructions that tell the cancer cell to grow and divide. 3. Administration and Dosing Standard Dosage: The typical dose is 160mg (four 40mg capsules) taken once daily. Consistency: It can be taken with or without food. Maintaining a daily routine at the same time is essential for therapeutic efficacy. Handling: Capsules must be swallowed whole and should not be chewed, dissolved, or opened. Clinical Side Effects & Safety Monitoring Fatigue: Significant tiredness or lack of energy is the most commonly reported side effect. Gastrointestinal: Decreased appetite, constipation, or diarrhea. Musculoskeletal: Back pain, joint pain (arthralgia), and an increased risk of falls or fractures. Neurological Risks: While rare, there is a potential risk of seizures; patients with a history of brain injury or seizures should be monitored closely. Cardiovascular: Potential for high blood pressure (hypertension) and ischemic heart disease. General: Hot flushes and peripheral edema (swelling of the extremities). Why Source Enzalieva 40mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva’s Enzalieva with full batch-specific traceability and COA. Logistics Authority: Expert handling of complex import regulations for London (UK), the USA, Australia, and South Africa. Bulk Supply Solutions: Competitive wholesale pricing for hospital groups, urology networks, and regional distributors. Regulatory Compliance: Every shipment is accompanied by GMP certificates and complete B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: Chat on WhatsApp

Palbolieva 100mg Capsule: Breakthrough CDK4/6 Inhibition for Advanced HR+/HER2- Breast Cancer Care Are you searching for a verified Palbolieva 100mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted breast cancer therapies. We provide a secure, high-standard supply chain for London & the UK, the USA, Australia, and South Africa, ensuring that critical cyclin-dependent kinase inhibitors reach oncology centers with 100% pharmaceutical integrity. Detailed Product Profile: What is Palbolieva 100mg? Palbolieva 100mg is an oral targeted therapy containing the active pharmaceutical ingredient Palbociclib. Manufactured by Allieva, this 100mg capsule is a potent CDK4/6 inhibitor. It has revolutionized the treatment landscape for hormone-driven breast cancers by specifically targeting the machinery that allows cancer cells to divide and multiply. 1. Therapeutic Indications HR+, HER2- Advanced Breast Cancer: For patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread to other parts of the body (metastatic). First-Line Combination Therapy: Frequently used in combination with an aromatase inhibitor (such as Letrozole) as the initial endocrine-based therapy for postmenopausal women. Second-Line Combination Therapy: Prescribed in combination with Fulvestrant for patients whose disease has progressed following prior endocrine therapy. 2. Mechanism of Action: Arresting the Cell Cycle Enzyme Inhibition: It targets two specific proteins called cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These proteins are often overactive in breast cancer cells. Phase Arrest: By blocking these kinases, Palbolieva prevents the cancer cell from progressing from the G1 phase to the S phase of the cell cycle. Proliferation Stop: This effectively locks the cancer cell in a non-dividing state, significantly slowing down tumor growth and delaying disease progression. 3. Administration and Dosing Cycle Management: Typically taken in a 21-day on, 7-day off cycle. This rest period allows the body's healthy cells, particularly blood cells, to recover. Timing: Palbolieva 100mg should be taken with food at approximately the same time each day to ensure optimal absorption. Consistency: Adherence to the prescribed cycle is vital for maintaining the “cell cycle arrest“ required to shrink or stabilize tumors. Clinical Side Effects & Safety Monitoring Neutropenia: The most common side effect is a decrease in white blood cells (Neutropenia). Regular complete blood counts (CBC) are mandatory before each cycle to monitor infection risk. Infections: Due to lowered blood counts, patients may be more susceptible to infections. Report fever or chills immediately. Gastrointestinal: Nausea, diarrhea, and stomatitis (mouth sores) are frequently observed clinical side effects. Dermatological: Potential for thinning of the hair (alopecia) or skin rashes. Fatigue & Dizziness: Significant tiredness (asthenia) or dizziness may occur, impacting daily activities. Precautions: Avoid grapefruit and grapefruit juice, as they can interfere with how the body processes the medication, leading to increased toxicity. Why Source Palbolieva 100mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva’s Palbolieva with full batch-specific traceability and COA. Logistics Authority: Expert handling of complex import regulations for London (UK), the USA, Australia, and South Africa. Wholesale Fulfillment: Competitive bulk pricing and steady inventory for hospital groups, breast cancer specialty clinics, and regional distributors. Regulatory Compliance: Every shipment is accompanied by GMP certificates and complete B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: Chat on WhatsApp

Palbolieva 125mg Capsule: Maximum Potency CDK4/6 Inhibition for Advanced HR+/HER2- Breast Cancer Care Are you searching for a verified Palbolieva 125mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted breast cancer therapies. We provide a secure, high-standard supply chain for London & the UK, the USA, Australia, and South Africa, ensuring that high-dose cyclin-dependent kinase inhibitors reach oncology centers with 100% pharmaceutical integrity. Detailed Product Profile: What is Palbolieva 125mg? Palbolieva 125mg is an oral targeted chemotherapy medication containing the active pharmaceutical ingredient Palbociclib. Manufactured by Allieva, the 125mg strength is the standard therapeutic starting dose for most patients. It belongs to a revolutionary class of drugs called CDK4/6 inhibitors, designed to specifically block the proteins that drive the rapid division of hormone-receptor-positive breast cancer cells. 1. Therapeutic Indications HR+, HER2- Metastatic Breast Cancer: For patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread. Initial Endocrine-Based Therapy: Often prescribed in combination with an aromatase inhibitor (like Letrozole or Anastrozole) as a first-line treatment for postmenopausal women or men. Progressive Disease Therapy: Used in combination with Fulvestrant for patients whose cancer has progressed after prior endocrine therapy. 2. Mechanism of Action: Arresting the Malignant Cell Cycle Kinase Blockade: It selectively inhibits Cyclin-Dependent Kinases 4 and 6 (CDK4/6). In many breast cancers, these kinases are overactive, pushing cells to divide uncontrollably. G1-Phase Arrest: By blocking these enzymes, Palbolieva prevents the cancer cell from moving from the growth phase (G1) to the DNA replication phase (S). Halting Proliferation: This results in “cell cycle arrest,“ which stabilizes the tumor, reduces its size, and significantly extends progression-free survival (PFS). 3. Administration and Dosing Schedule Standard Regimen: Typically administered in a 28-day cycle—one 125mg capsule daily for 21 consecutive days, followed by 7 days of rest. Bioavailability: Palbolieva 125mg should be taken with food at approximately the same time each day to ensure the drug is absorbed correctly by the body. Handling: Capsules must be swallowed whole; they should not be opened, crushed, or chewed. Clinical Side Effects & Safety Monitoring Neutropenia: A significant decrease in white blood cells (neutrophils) is common. Regular complete blood counts (CBC) are mandatory before starting each cycle. Infection Risk: Due to lower blood counts, patients must monitor for signs of fever or chills. Gastrointestinal: Nausea, diarrhea, and mouth sores (stomatitis) are frequently observed. General Fatigue: Significant tiredness or lack of energy is a known clinical side effect. Dermatological: Potential for thinning of the hair (alopecia) or dry skin. Drug Interactions: Avoid grapefruit products and certain herbal supplements like St. John’s Wort, as they can alter the drug's efficacy and toxicity levels. Why Source Palbolieva 125mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva’s Palbolieva with full batch-specific traceability and COA. Logistics Authority: Expert handling of complex import regulations for London (UK), the USA, Australia, and South Africa. Bulk Supply Solutions: Competitive wholesale pricing for hospital groups, specialty oncology pharmacies, and regional distributors. Regulatory Compliance: Every shipment is accompanied by GMP certificates and complete B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: Chat on WhatsApp

Hydlieva 500mg Capsule: Potent Antineoplastic Therapy for Hematologic and Solid Tumor Management Are you searching for a reliable Hydlieva 500mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced cytotoxic therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Hydlieva 500mg? Hydlieva 500mg is an oral antineoplastic (anti-cancer) therapy containing the active pharmaceutical ingredient Hydroxyurea (also known as Hydroxycarbamide). Manufactured by Allieva Pharma Pvt Ltd, this 500mg capsule is a versatile antimetabolite used to treat a variety of proliferative disorders. It is a vital component in managing both malignant blood cancers and certain non-cancerous blood conditions. 1. Therapeutic Indications Chronic Myeloid Leukemia (CML): Specifically for resistant cases to help control the overproduction of white blood cells. Head and Neck Cancers: Used in combination with radiotherapy for locally advanced squamous cell carcinomas (excluding the lip). Sickle Cell Anemia: Indicated to reduce the frequency of painful crises and the need for blood transfusions in adult and pediatric patients. Polycythemia Vera & Essential Thrombocythemia: Used to manage excessive production of red blood cells and platelets, reducing the risk of blood clots and stroke. Cervical Cancer: Occasionally utilized as a radiosensitizer in comprehensive treatment protocols. 2. Mechanism of Action: Ribonucleotide Reductase Inhibition DNA Synthesis Inhibition: It acts as a potent inhibitor of the enzyme ribonucleotide reductase. This enzyme is essential for converting ribonucleotides into deoxyribonucleotides (the building blocks of DNA). S-Phase Specificity: By blocking DNA synthesis, Hydlieva prevents cancer cells from replicating their genetic material, halting them in the S-phase of the cell cycle. Fetal Hemoglobin Induction: In sickle cell disease, it increases the production of fetal hemoglobin (HbF), which prevents red blood cells from “sickling“ and improves oxygen transport. 3. Administration and Dosage Management Standard Dosing: The dose is highly individualized based on the patient's body weight, blood counts, and the specific condition being treated. Administration: Capsules should be swallowed whole. If the patient cannot swallow them, the contents may be dissolved in a glass of water and taken immediately. Safety Handling: As a cytotoxic agent, caregivers should wear disposable gloves when handling the capsules or powder to avoid direct skin contact. Clinical Side Effects & Safety Monitoring Bone Marrow Suppression: The most significant risk is a drop in white blood cells (leukopenia), platelets (thrombocytopenia), and red blood cells (anemia). Regular blood counts are mandatory. Cutaneous Toxicities: Potential for skin ulcers, darkening of the skin or nails, and in rare cases, secondary skin cancers (monitoring and sun protection are advised). Gastrointestinal Health: Nausea, vomiting, diarrhea, and mouth sores (stomatitis) are common side effects. Pulmonary Monitoring: Rare cases of interstitial lung disease or fibrosis have been reported; patients should report any new shortness of breath. Why Source Hydlieva 500mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Hydlieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Acalieva 100mg Capsule: Next-Generation BTK Inhibition for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Are you searching for a reliable Acalieva 100mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of highly selective targeted therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical hematology-oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Acalieva 100mg? Acalieva 100mg is an oral targeted therapy containing the active pharmaceutical ingredient Acalabrutinib. Manufactured by Allieva Pharma Pvt Ltd, this 100mg capsule is a second-generation, highly selective Bruton’s Tyrosine Kinase (BTK) inhibitor. It represents a significant advancement in the treatment of B-cell malignancies, offering improved selectivity and a potentially better safety profile compared to first-generation BTK inhibitors. 1. Therapeutic Indications Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL): Indicated as a first-line treatment or for patients who have received at least one prior therapy. Mantle Cell Lymphoma (MCL): Used for adult patients who have received at least one prior therapy for their disease. Relapsed or Refractory B-cell Malignancies: Providing a potent oral option for patients whose cancer has returned after initial treatments. 2. Mechanism of Action: Selective BTK Blockade BTK Inhibition: It forms a covalent bond with a cysteine residue (Cys481) in the BTK active site. BTK is a signaling molecule of the B-cell antigen receptor (BCR) pathway. Interrupting Growth Signals: By blocking BTK, Acalieva inhibits the signaling that leads to B-cell proliferation, trafficking, chemotaxis, and adhesion. High Selectivity: As a second-generation inhibitor, it is designed to be more selective for BTK over other kinases (like EGFR or ITK), which helps in reducing off-target side effects. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is 100mg taken orally twice daily (approximately 12 hours apart). Administration: Capsules should be swallowed whole with water. They can be taken with or without food. Acid-Reducing Agents: Patients should exercise caution with Proton Pump Inhibitors (PPIs), as they can affect the absorption of the medication. Consult an oncologist for timing with H2-receptor antagonists or antacids. Clinical Side Effects & Safety Monitoring Hematological Safety: Potential for Cytopenias (anemia, neutropenia, or thrombocytopenia). Periodic Complete Blood Counts (CBC) are necessary. Cardiovascular Health: Monitoring for Atrial Fibrillation and hypertension, though risks may be lower compared to earlier BTK inhibitors. Hemorrhage Risks: Patients should be monitored for signs of bleeding, especially those on concurrent antiplatelet or anticoagulant therapy. Infection Control: Increased susceptibility to opportunistic infections; patients should report any fever or signs of illness immediately. Headache: A common side effect often reported at the start of treatment, which usually subsides over time. Why Source Acalieva 100mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Acalieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

CRIZLIEVA 250mg Tablet: Targeted ALK and ROS1 Inhibition for Advanced Non-Small Cell Lung Cancer Are you searching for a reliable CRIZLIEVA 250 mg tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced tyrosine kinase inhibitors. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is CRIZLIEVA 250mg? CRIZLIEVA 250mg is an oral targeted therapy containing the active pharmaceutical ingredient Crizotinib. Manufactured by Allieva Pharma Pvt Ltd, this 250mg tablet is a first-in-class receptor tyrosine kinase inhibitor. It is specifically designed to treat patients with non-small cell lung cancer (NSCLC) that is driven by specific genetic alterations, offering a precision medicine approach that is more effective than traditional chemotherapy for these subtypes. 1. Therapeutic Indications ALK-Positive Metastatic NSCLC: Indicated for patients whose tumors are positive for anaplastic lymphoma kinase (ALK) as detected by an approved test. ROS1-Positive Metastatic NSCLC: Specifically utilized for patients with metastatic non-small cell lung cancer whose tumors are ROS1-positive. Advanced Disease Management: Used as both a first-line therapy and for patients who have progressed on previous treatments, helping to shrink or slow the growth of tumors. 2. Mechanism of Action: Molecular Signal Disruption Kinase Inhibition: It inhibits the C-Met/Hepatocyte Growth Factor Receptor (HGFR), ROS1, and ALK tyrosine kinases. Targeting Mutations: In ALK-positive or ROS1-positive cancers, these proteins are overactive, sending continuous “grow“ signals to the cells. Crizotinib binds to these proteins and “turns off“ the signal. Halting Proliferation: By interrupting these pathways, the medication prevents the survival and proliferation of malignant cells, often leading to significant tumor regression. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is 250mg taken orally twice daily. Administration: Can be taken with or without food. Tablets must be swallowed whole; do not crush, dissolve, or open the capsules. Monitoring: Dosage may be adjusted by an oncologist based on individual safety and tolerability. Clinical Side Effects & Safety Monitoring Hepatotoxicity: Potential for drug-induced liver injury; periodic Liver Function Tests (LFTs) are mandatory. Ocular Effects: Visual disturbances (such as light flashes or blurred vision) are common but often transient. Pneumonitis: Rare but serious risk of severe or life-threatening drug-related lung inflammation. Cardiovascular Safety: Monitoring for QT interval prolongation and bradycardia (slow heart rate). Gastrointestinal Health: Nausea, vomiting, and diarrhea are common; hydration and supportive care are recommended. Why Source CRIZLIEVA 250mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s CRIZLIEVA with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Ibrulieva 140mg Capsule: Breakthrough Bruton’s Tyrosine Kinase (BTK) Inhibition for B-Cell Malignancies Are you searching for a reliable Ibrulieva 140mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of first-in-class targeted therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical hematology-oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Ibrulieva 140mg? Ibrulieva 140mg is an oral targeted therapy containing the active pharmaceutical ingredient Ibrutinib. Manufactured by Allieva Pharma Pvt Ltd, this 140mg capsule is a potent, irreversible inhibitor of Bruton’s Tyrosine Kinase (BTK). It has transformed the treatment landscape for various B-cell cancers by providing a non-chemotherapy alternative that specifically targets the molecular pathways cancer cells use to survive and multiply. 1. Therapeutic Indications Chronic Lymphocytic Leukemia (CLL) & Small Lymphocytic Lymphoma (SLL): Indicated for both previously untreated and relapsed/refractory patients, including those with high-risk genetic markers like 17p deletion. Mantle Cell Lymphoma (MCL): For adult patients who have received at least one prior therapy. Waldenström’s Macroglobulinemia (WM): A rare type of non-Hodgkin lymphoma; used as monotherapy or in combination with Rituximab. Marginal Zone Lymphoma (MZL): For patients who require systemic therapy and have received at least one prior anti-CD20-based therapy. Chronic Graft Versus Host Disease (cGVHD): For adult and pediatric patients after the failure of one or more lines of systemic therapy. 2. Mechanism of Action: Irreversible Signal Blockade BTK Inhibition: It forms a strong covalent bond with a cysteine residue (Cys-481) in the BTK active site. BTK is a critical signaling molecule for the B-cell antigen receptor (BCR) pathway. Survival Signal Interruption: By blocking BTK, Ibrulieva prevents the activation of downstream survival pathways (like NF-κB and MAPK). Apoptosis and Homed-Inhibition: It inhibits malignant B-cell proliferation, adhesion, and migration to lymphoid tissues, effectively “starving“ the cancer cells of the signals they need to stay alive. 3. Administration and Dosage Management Standard Dosing: Dosing varies by indication. For CLL and WM, the standard dose is 420mg (three 140mg capsules) once daily. For MCL and MZL, the dose is 560mg (four 140mg capsules) once daily. Administration: Should be taken once daily at approximately the same time. Capsules must be swallowed whole with a glass of water. Hydration: Patients are encouraged to maintain adequate hydration while on therapy.Avoidances: Do not open, break, or chew the capsules. Avoid grapefruit and Seville oranges, as they may increase drug levels in the blood. Clinical Side Effects & Safety Monitoring Hemorrhage (Bleeding): Increased risk of bruising and serious bleeding events. Therapy may need to be withheld 3–7 days before and after surgery. Atrial Fibrillation & Flutter: Monitoring for irregular heartbeat, dizziness, or fainting is essential, particularly in patients with cardiac risk factors. Infections: Risk of serious bacterial, viral, or fungal infections. Any fever or chills should be reported immediately. Cytopenias: Potential for Neutropenia and Thrombocytopenia; monthly Complete Blood Counts (CBC) are standard. Hypertension: New or worsening high blood pressure should be monitored and managed clinically. Why Source Ibrulieva 140mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Ibrulieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

THALIDOMIDE 50mg Capsule: Precision Immunomodulation for Multiple Myeloma and Erythema Nodosum Leprosum (ENL) Are you searching for a reliable THALIDOMIDE 50mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of highly regulated immunomodulatory drugs (IMiDs). We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology and leprostatic medications reach institutional pharmacies with 100% pharmaceutical integrity and compliance. Detailed Product Profile: What is THALIDOMIDE 50mg? THALIDOMIDE 50mg is an oral therapeutic agent containing the active ingredient Thalidomide. Originally known for its sedative properties, it has been repurposed as a powerful antineoplastic and anti-inflammatory medication. Manufactured under stringent quality standards, this 50mg capsule is primarily utilized in oncology to disrupt cancer cell growth and in infectious disease to manage severe inflammatory complications of Hansen's disease (leprosy). 1. Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for the treatment of newly diagnosed multiple myeloma. It is a cornerstone of “triplet“ and “quadruplet“ therapy regimens. Erythema Nodosum Leprosum (ENL): Indicated for the acute treatment of the cutaneous manifestations of moderate to severe ENL and as maintenance therapy to prevent recurrence. Off-Label Oncology Uses: Occasionally utilized in specialized protocols for refractory cancers, including certain brain tumors and Kaposi's sarcoma, under strict medical supervision. 2. Mechanism of Action: The “Cereblon“ Pathway Cereblon Binding: It binds to Cereblon (CRBN), part of an E3 ubiquitin ligase complex. This binding triggers the selective degradation of specific transcription factors (Aiolos and Ikaros), which are essential for the survival of B-cells and myeloma cells. Anti-Angiogenesis: It prevents the formation of new blood vessels (angiogenesis) that tumors require to grow, effectively “starving“ the malignant mass. Cytokine Modulation: It inhibits the production of Tumor Necrosis Factor-alpha (TNF-α) and other pro-inflammatory cytokines, which is the primary reason for its efficacy in treating ENL. Immune Enhancement: It stimulates T-cells and Natural Killer (NK) cells to better recognize and attack cancerous cells 3. Administration and Dosing Management Standard Dosing: The typical oncology starting dose is 200mg once daily (four 50mg capsules), though 50mg is often used for dose titration and maintenance. Timing: Should be taken once daily at bedtime, at least 1 hour after the evening meal, to minimize the impact of its sedative effects. Safety Handling: Capsules must be swallowed whole. Healthcare providers and caregivers should handle capsules with care; if a capsule is broken, avoid contact with skin or inhalation of the powder. Clinical Side Effects & Safety Monitoring Embryo-Fetal Toxicity (Teratogenicity): This is the most critical risk. Thalidomide causes severe birth defects. Use is strictly governed by REMS/S.T.E.P.S. programs globally. Peripheral Neuropathy: Monitoring for tingling, numbness, or pain in the hands and feet. This can be permanent if not caught early. Venous Thromboembolism (VTE): Increased risk of DVT and pulmonary embolism, especially when combined with steroids. Thromboprophylaxis (aspirin or anticoagulants) is often prescribed. Somnolence and Fatigue: Due to its sedative nature, patients should avoid driving or operating heavy machinery. Bradycardia: Monitoring of heart rate is advised, especially in patients with pre-existing cardiac conditions. Why Source THALIDOMIDE 50mg from Ernest Oncology? Verified Authenticity: Direct sourcing of high-integrity Thalidomide with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex export regulations and specialized shipping requirements for the USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

The Comprehensive Guide to Nilotinib Capsules 200mg (Tasigna Generic) In the landscape of modern hematology, Nilotinib Capsules 200mg represent a critical advancement in the treatment of chronic myeloid leukemia (CML). As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this life-saving tyrosine kinase inhibitor (TKI) is accessible to healthcare systems and patients in London, New York, Sydney, Johannesburg, and beyond. Product Specifications Brand Name: Ernest-Oncology (Nilotinib Acetate) Concentration: 200mg per capsule Dosage Form: Oral Capsule Primary Indication: Treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) Storage: Store at room temperature (20°C to 25°C), away from moisture and direct light. Mechanism of Action: How It Works Targeted Therapy: It works by binding to and inhibiting the Bcr-Abl protein, an abnormal tyrosine kinase produced by the Philadelphia chromosome in leukemia cells. Halting Cancer Progression: By blocking the signals that tell cancer cells to multiply, Nilotinib slows down or stops the uncontrolled production of abnormal white blood cells in the bone marrow. Therapeutic Indications & Administration Indications: Treatment of newly diagnosed Ph+ CML in the chronic phase, as well as cases resistant or intolerant to prior therapies like imatinib. Administration: * The standard adult dose is often 300mg to 400mg taken twice daily. Empty Stomach Requirement: It must be taken on an empty stomach—at least 1 hour before or 2 hours after a meal—as food can significantly increase drug absorption to dangerous levels. Clinical Side Effects & Safety Common Effects: Headache, nausea, fatigue, rash, and muscle or joint pain. Serious Warnings: Nilotinib carries a “black box“ warning for QT prolongation, which can lead to irregular heart rhythms. Metabolic & Blood Monitoring: It may cause myelosuppression (low blood cell counts), pancreatitis, or liver enzyme elevations. Contraindications: It is strictly contraindicated during pregnancy and breastfeeding. Avoid grapefruit and grapefruit juice as they interfere with drug metabolism. Why Source from Ernest Oncology? United Kingdom (London): Supplying cost-effective oncology alternatives to private clinics and public healthcare networks. USA: Providing bulk supply solutions that adhere to stringent quality benchmarks for clinical research and patient care. Australia: Ensuring reliable supply through “Special Access Scheme“ (SAS) channels for life-saving medications. South Africa: Bridging the pharmaceutical gap with affordable, high-tier oncology exports. 📞 Contact Ernest Oncology —Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: [exports@ernestpharmaceuticals.com](mailto:exports@ernestpharmaceuticals.com) 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 [https://wa.me/919359902383]

Comprehensive Product Authority Guide: Temalieva 20mg (Temozolomide) Temalieva 20mg, formulated with the active pharmaceutical ingredient Temozolomide, is a potent oral alkylating antineoplastic agent. It is widely recognized and utilized in neuro-oncology for the treatment of aggressive forms of brain tumors. 1. Advanced Mechanism of Action DNA Methylation: MTIC works by methylating DNA at the O6 and N7 positions of guanine. Cell Cycle Arrest: This methylation damages the genetic material of cancer cells, leading to DNA double-strand breaks and inducing apoptosis (programmed cell death) in rapidly dividing tumor cells. Blood-Brain Barrier Penetration: Because it is highly lipophilic, it crosses the blood-brain barrier easily, making it uniquely effective against primary and secondary brain malignancies. 2. Therapeutic Indications Glioblastoma Multiforme (GBM): Administered in combination with focal radiotherapy as an initial treatment, followed by maintenance therapy to prevent recurrence. Anaplastic Astrocytoma: Prescribed for patients with refractory or progressive malignant glioma, including anaplastic astrocytoma. Other Malignancies: Clinical evaluation has shown efficacy in certain systemic cancers and targeted neuro-oncology protocols. 3. Dosage and Administration Strength: Available as 20mg oral capsules. Administration Protocol: To minimize nausea and ensure consistent bioavailability, the medication should be taken consistently (either always on an empty stomach or always with a light meal) at the same time each day. Handling Instructions: Capsules must be swallowed whole with a full glass of water. They should not be opened, chewed, crushed, or split, as the contents are highly cytotoxic. 4. Safety Profile and Side Effect Management Common Side Effects: Nausea, vomiting, fatigue, headache, and constipation. Hematological Effects: Myelosuppression (reduced red/white blood cell and platelet counts), which increases the risk of serious infections. Monitoring: Frequent complete blood counts (CBC) and liver function tests are recommended throughout the treatment cycle. Why Source from Ernest Oncology? Ernest Oncology—a specialized division of Ernest Pharmaceutical Pvt. Ltd.—is a trusted global exporter, bulk supplier, and distributor. We facilitate the secure, temperature-controlled delivery of life-saving specialty pharmaceuticals worldwide, bridging the gap between state-of-the-art manufacturing in India and the requirements of global healthcare networks. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

The Comprehensive Guide to Temalieva 250 mg Capsules In precision neuro-oncology and general cancer care, Temalieva 250 mg capsules (containing the active ingredient Temozolomide) stand as a critical therapeutic agent for treating aggressive brain tumors. As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this life-saving medication is accessible to hospitals, pharmacies, and healthcare systems in London, the UK, the USA, Australia, and South Africa with full regulatory compliance. Product SpecificationsFeatureDetailBrand NameTemalieva 250 (Temozolomide Capsules IP)Strength250 mgDosage FormOral Hard Gelatin CapsulePrimary IndicationGlioblastoma multiforme & anaplastic astrocytomaStorageStore below 25°C in a cool, dry place. Protect from moisture and light. Mechanism of Action: How It Works DNA Alkylation: Once ingested, Temozolomide readily crosses the blood-brain barrier. At physiological pH, it is converted into the active compound MTIC. Interfering with Replication: MTIC methylates DNA at specific locations, which causes DNA strand breaks and cross-linking. This process inhibits the multiplication and growth of rapidly dividing cancer cells, ultimately leading to programmed cell death (apoptosis). Therapeutic Indications & Administration Glioblastoma Multiforme (GBM): Used for newly diagnosed GBM patients in combination with focal radiation therapy, followed by maintenance therapy. Refractory Anaplastic Astrocytoma: Treatment for patients experiencing tumor recurrence or progression after standard therapy. Administration Guidelines Dosing Schedule: Dosing is calculated based on the patient's body surface area (BSA). Ingestion: Swallow the capsules whole with a full glass of water. Do not open, crush, or chew the capsule contents to prevent exposure to the active drug. Minimizing Side Effects: To reduce the incidence of nausea and vomiting, patients are often advised to take the medication on an empty stomach or at bedtime. Clinical Side Effects & Safety Profile Common Side Effects: Nausea, vomiting, headache, fatigue, constipation, and loss of appetite. Prophylactic antiemetics are frequently prescribed. Myelosuppression: The most serious clinical risk is a decrease in bone marrow function, which leads to reduced white blood cell and platelet counts. This increases susceptibility to infections and bruising or bleeding. Liver Function: Patients should undergo regular liver function tests (LFTs) due to the potential for hepatotoxicity. Contraindications: It is contraindicated during pregnancy and breastfeeding due to the risk of fetal harm. Male patients must use effective contraception during treatment and for at least 3 months afterward. Why Source from Ernest Oncology? United Kingdom (London): Providing high-quality, cost-effective generic alternatives for private and public healthcare systems. USA: Delivering bulk quantities that comply with international documentation and safety standards. Australia: Facilitating secure access through compliant supply channels such as the “Special Access Scheme“ (SAS). South Africa: Bridging critical gaps in the oncology market with affordable, high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Lenid 10mg Capsule (Lenalidomide): Precision Immunotherapy for Hematological Malignancies Lenid 10mg Capsule is a high-potency anti-cancer medication featuring the active pharmaceutical ingredient Lenalidomide. Classified as an immunomodulatory imide drug (IMiD), Lenid 10mg is a critical therapeutic agent used globally to treat various forms of blood and bone marrow cancers. Manufactured by Natco Pharma Ltd., a global pioneer in oncology generics, Lenid is recognized for its high efficacy in modulating the immune response to identify and destroy malignant cells while inhibiting tumor growth. Therapeutic Indications and Clinical Usage Lenid 10mg is a primary choice in international oncology protocols for: Multiple Myeloma (MM): Indicated for adult patients with newly diagnosed multiple myeloma, often used in combination with dexamethasone. It is also a gold-standard choice for maintenance therapy following autologous stem cell transplantation (ASCT). Myelodysplastic Syndromes (MDS): Specifically used for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma (FL): Used in combination with rituximab for previously treated adult patients with follicular or marginal zone lymphoma. Mechanism of Action: How Lenid 10mg Works Lenid exerts its therapeutic effects through a multi-dimensional biological approach: Immune System Augmentation: It enhances the activity of T-cells and Natural Killer (NK) cells, empowering the body's natural defenses to destroy cancer cells more aggressively. Direct Antitumor Activity: It induces cell cycle arrest and triggers apoptosis (programmed cell death) in malignant hematopoietic cells. Anti-Angiogenesis: It blocks the formation of new blood vessels that tumors rely on for oxygen and nutrients, effectively “starving“ the tumor. Cytokine Regulation: It inhibits the production of pro-inflammatory cytokines such as TNF-alpha and IL-6, which are known to fuel the proliferation of myeloma cells. Dosage and Administration Guidelines Dosing Schedule: Usually administered in 28-day cycles. The 10 mg strength is frequently utilized for maintenance therapy or adjusted dosing based on patient tolerance and renal function. Administration: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed. Consistency: Can be taken with or without food, but should be taken at approximately the same time each day to maintain steady therapeutic levels. Clinical Monitoring: Dosage adjustments are strictly managed by oncologists based on renal function and blood cell counts. Safety Profile and Side Effect Management As a potent targeted therapy, Lenid 10mg requires vigilant professional oversight: 1. Hematological Vigilance The most common side effects include neutropenia (low white blood cells) and thrombocytopenia (low platelets). Regular Complete Blood Counts (CBC) are mandatory to monitor for infection or bleeding risks. 2. Thromboembolism Prophylaxis There is an increased risk of blood clots (DVT or Pulmonary Embolism). Patients are typically prescribed prophylactic anticoagulants (like aspirin or heparin) concurrently. 3. Embryo-Fetal Toxicity (REMS) Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs (REMS) is mandatory for all patients of reproductive potential. 4. General Side Effects Commonly reported symptoms include fatigue, diarrhea, muscle cramps, and skin rashes. These are usually managed with supportive care. Storage and Handling Instructions Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F). Protection: Keep capsules in the original blister packaging to protect from light and moisture. Safety: Caregivers should avoid direct skin contact with the capsules. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

The Professional Guide to Acalnib 100mg (Acalabrutinib) Capsule: Targeted BTK Inhibition & Global Supply In the modern treatment of hematological malignancies, Acalnib 100mg Capsule has become a vital targeted therapy. As a leading pharmaceutical exporter from India, Ernest Oncology (Group of Ernest Pharmaceutical Pvt. Ltd.) ensures that healthcare providers and institutional buyers in the USA, UK, UAE, Australia, Singapore, South Africa, Europe, the Middle East, Africa, and Asia have seamless access to this high-quality Acalabrutinib generic. What is Acalnib 100mg (Acalabrutinib)? Acalnib 100mg contains Acalabrutinib, a potent and highly selective second-generation Bruton's Tyrosine Kinase (BTK) inhibitor. BTK is a key enzyme in the B-cell receptor signaling pathway, which is essential for the survival, proliferation, and spread of malignant B-cells. Acalnib is engineered to offer improved selectivity, potentially leading to fewer off-target side effects compared to earlier-generation BTK inhibitors. Therapeutic Indications Acalnib 100mg is globally recognized for the treatment of adult patients with: Chronic Lymphocytic Leukemia (CLL): Both as a first-line treatment and for patients who have relapsed or are refractory. Small Lymphocytic Lymphoma (SLL): Often treated with the same protocols as CLL due to their biological similarities. Mantle Cell Lymphoma (MCL): Specifically for adult patients who have received at least one prior therapy for their malignancy. Mechanism of Action Acalnib works through a precise molecular mechanism: Selective Binding: It forms a covalent bond with a specific cysteine residue in the BTK active site. Signal Blockade: This inhibition stops the B-cell receptor (BCR) signaling pathway. Halting Progression: By disrupting these signals, Acalnib prevents the growth and survival of cancerous B-cells, leading to tumor shrinkage and disease stabilization. Product Specifications & Clinical Usage Technical Specifications Active Ingredient: Acalabrutinib (100 mg) Form: Oral Capsule. Manufacturer: Hetero Healthcare Ltd. (marketed globally via Ernest Oncology). Packaging: 1 Bottle of 30 Capsules. Storage: Store at room temperature between 20°C and 25°C (68°F and 77°F). Keep in the original container to protect from light and moisture. Dosage and Administration Standard Dose: The recommended dose is 100 mg (one capsule) taken twice daily (approximately 12 hours apart). Method: Capsules should be swallowed whole with a glass of water. Do not open, break, chew, or crush the capsules. Dietary Note: Acalnib can be taken with or without food. Antacid Warning: Avoid taking proton pump inhibitors (PPIs) while on Acalnib. If you must use antacids, take them at least 2 hours before or 2 hours after your Acalnib dose. Safety & Side Effects Common side effects may include: Headache and fatigue. Diarrhea or nausea. Musculoskeletal (muscle, bone, or joint) pain. Upper respiratory tract infections. Serious Precautions: Acalnib may increase the risk of bleeding or heart rhythm problems (like atrial fibrillation). Regular blood count (CBC) monitoring is required to manage potential anemia or low platelet counts. Why Partner with Ernest Oncology for Global Export? Ernest Oncology specializes in the specialized logistics and regulatory compliance required for high-value oncology medications like Acalnib 100mg. Global Wholesale Reach: We are a verified exporter to major markets, including the USA, UK, UAE, Australia, and Singapore, supporting hospital tenders and large-scale distributors. Bulk Supplier Advantage: We offer competitive B2B pricing for institutional buyers across Africa and the Middle East, ensuring affordable access to targeted cancer therapies. Compliance & Quality: Our shipments are accompanied by all necessary regulatory documentation, including Certificate of Analysis (CoA) and Country of Origin (COO), and are packed in climate-controlled conditions. 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Pomavia 2 mg Capsule (Pomalidomide): Comprehensive Clinical Profile and Global Export Solutions Pomavia 2 mg Capsule is a highly potent immunomodulatory drug (IMiD) containing the active pharmaceutical ingredient Pomalidomide. Specifically engineered for patients with complex hematological malignancies, Pomavia represents a third-generation treatment option for those who have developed resistance to earlier therapies. As a vital component in modern oncology, Pomavia is recognized for its ability to target cancer cells through multiple biological pathways. Therapeutic Indications and Clinical Use Pomavia 2 mg is primarily indicated for the following medical conditions: Relapsed and Refractory Multiple Myeloma (RRMM): It is prescribed for adult patients who have received at least two prior therapies, including both Lenalidomide and a proteasome inhibitor (such as Bortezomib), and have demonstrated disease progression. Combination Regimens: For maximum therapeutic effect, Pomavia is typically used in combination with low-dose Dexamethasone. Kaposi Sarcoma: In specific clinical scenarios, it is utilized for patients with AIDS-related Kaposi Sarcoma (KS) or for HIV-negative patients who require advanced immunomodulatory intervention. The Mechanism: How Pomavia 2 mg Works The efficacy of Pomavia is rooted in its triple-action mechanism: Tumor Cell Inhibition: It directly binds to the cereblon protein, leading to the degradation of essential transcription factors, which triggers apoptosis (programmed cell death) in malignant cells. Immune System Modulation: It enhances the body’s natural defense by stimulating T-cells and Natural Killer (NK) cells, empowering the immune system to actively hunt and destroy cancer cells. Anti-Angiogenesis: It blocks the development of new blood vessels that tumors rely on for oxygen and nutrients, effectively inhibiting the growth and spread of the disease. Dosage and Administration Guidelines Standard Regimen: The dose is typically 4mg or 2mg taken once daily on days 1–21 of repeated 28-day cycles. Intake Instructions: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed to ensure the medication is released correctly in the body. Timing: It is best taken at the same time each day, with or without food. Monitoring: Treatment continues until disease progression or until a physician determines that the side effects outweigh the clinical benefits. Safety Profile and Patient Management Managing the safety of Pomavia 2 mg is a critical part of the treatment journey: Hematological Monitoring The most common side effects are neutropenia (low white blood cell count) and thrombocytopenia (low platelet count). Regular blood tests (CBC) are mandatory during the first few months of treatment to monitor for infection risks or bleeding. Thromboembolism Prophylaxis Patients taking Pomavia have a heightened risk of blood clots. Standard care involves the use of prophylactic anticoagulants (like aspirin or heparin) to minimize the risk of deep vein thrombosis (DVT) or pulmonary embolism. Infection Control Due to the immunomodulatory nature of the drug, patients may be more susceptible to bacterial or viral infections. Any signs of fever, chills, or persistent cough must be reported to the oncologist immediately. Embryo-Fetal Toxicity Pomalidomide is known to cause severe birth defects. Strict adherence to pregnancy prevention programs (REMS) is mandatory for all patients of reproductive potential. Storage and Handling Guidelines Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F). Protection: Keep capsules in their original blister packaging to shield them from moisture and light. Handling: Caregivers should handle capsules with care and avoid direct skin contact with the powder inside. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Lenakast 25mg Capsule (Lenalidomide): Comprehensive Clinical Profile & Global Supply Guide Lenakast 25mg Capsule is a high-potency immunomodulatory drug (IMiD) containing the active pharmaceutical ingredient Lenalidomide. It is a cornerstone therapy in modern hematology and oncology, specifically designed to treat various plasma cell dyscrasias and complex blood cancers. As a structural analogue of thalidomide, Lenakast 25mg offers a targeted approach to inhibiting tumor growth while stimulating the body's natural immune response. Manufactured by Aprazer Healthcare, Lenakast is a trusted choice for oncology centers worldwide. Therapeutic Indications and Clinical Usage Lenakast 25mg is extensively utilized across global oncology protocols for: Multiple Myeloma (MM): Used in combination with dexamethasone for patients with newly diagnosed multiple myeloma or those who have received at least one prior therapy. It is also a primary choice for maintenance therapy following autologous stem cell transplantation (ASCT). Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after two prior therapies, providing a vital line of defense. Follicular Lymphoma & Marginal Zone Lymphoma: Employed in combination with rituximab for previously treated patients to achieve better remission rates and progression-free survival. The Mechanism: How Lenakast 25mg Works Lenakast exerts its anti-cancer effects through a sophisticated multi-pathway mechanism: Immune Modulation: It enhances T-cell and Natural Killer (NK) cell-mediated immunity, significantly increasing the body's innate ability to identify and destroy malignant cells. Anti-Angiogenesis: It blocks the secretion of vascular endothelial growth factor (VEGF), effectively preventing the formation of new blood vessels that tumors need to survive and spread. Direct Cytotoxicity: It induces cell cycle arrest and apoptosis (programmed cell death) specifically in hematopoietic tumor cells. Anti-Inflammatory Action: It inhibits the production of pro-inflammatory cytokines such as TNF-α and various Interleukins (IL-1, IL-6, and IL-12). Dosage and Administration Guidelines Cycle-Based Dosing: Typically administered in 28-day cycles. For multiple myeloma, the standard dose is 25 mg taken orally once daily on Days 1–21, followed by a 7-day rest period. Administration: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed. Timing: Can be taken with or without food, but should be taken at the same time each day to maintain steady therapeutic levels. Renal Monitoring: Since the drug is primarily excreted by the kidneys, dosage adjustments are strictly managed for patients with impaired renal function. Safety Profile and Side Effect Management Clinical management of Lenakast 25mg requires vigilant professional oversight: 1. Hematological Support The most frequent side effects are neutropenia (low white blood cells) and thrombocytopenia (low platelets). Regular blood counts (CBC) are mandatory to monitor for infection or bleeding risks. If counts drop too low, a dose reduction or temporary pause is usually implemented. 2. Thromboembolism Prophylaxis There is a significantly increased risk of blood clots (DVT or Pulmonary Embolism). Patients are almost always prescribed prophylactic anticoagulants (like aspirin or heparin) alongside Lenakast. 3. Embryo-Fetal Toxicity (REMS) Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs is mandatory for all patients of reproductive potential. 4. General Side Effects Commonly reported symptoms include fatigue, diarrhea, muscle cramps, and skin rashes. These are typically managed with supportive care, adequate hydration, and symptomatic medication. Storage and Handling Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F). Security: Keep in the original blister pack to protect from light and moisture. Safety: Caregivers should wear gloves if handling the capsules directly to avoid accidental skin exposure to the active powder. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ WHO-GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Lenmid 25mg Capsule is a high-potency immunomodulatory drug (IMiD) containing the active pharmaceutical ingredient Lenalidomide. It is a cornerstone therapy in modern hematology and oncology, specifically designed to treat various plasma cell dyscrasias and complex blood cancers. Manufactured by Cipla Ltd., a global pharmaceutical leader, Lenmid 25mg is recognized for its high efficacy, safety standards, and role in extending survival rates for patients worldwide. Therapeutic Indications and Clinical Usage Lenalidomide 25 mg is extensively utilized across international oncology protocols for: Multiple Myeloma (MM): Used in combination with dexamethasone for newly diagnosed patients or those who have failed at least one prior therapy. It is also the gold standard for maintenance therapy post-autologous stem cell transplantation (ASCT). Myelodysplastic Syndromes (MDS): Specifically indicated for transfusion-dependent anemia caused by low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after two prior therapies. Follicular & Marginal Zone Lymphoma: Often used in combination with Rituximab for patients previously treated for these indolent lymphomas. Mechanism of Action: How Lenmid 25mg Works Lenmid exerts its anti-cancer effects through a multi-faceted biological approach: Direct Cytotoxicity: It binds to the cereblon E3 ubiquitin ligase complex, leading to the degradation of essential transcription factors, which triggers apoptosis (programmed cell death) in malignant cells. Immune System Enhancement: It stimulates the production of Interleukin-2 (IL-2) and Interferon-gamma (IFN-$gamma$), which enhances the activity of T-cells and Natural Killer (NK) cells to actively destroy tumors. Anti-Angiogenesis: It blocks the secretion of pro-angiogenic factors like VEGF, effectively starving the tumor of the blood supply it needs to grow. Anti-Inflammatory Action: It reduces the production of pro-inflammatory cytokines such as TNF-$alpha$, altering the bone marrow microenvironment to make it less hospitable for cancer cells. Dosage and Administration Guidelines Standard Regimen: Typically administered in 28-day cycles. In multiple myeloma, the standard dose is 25 mg taken orally once daily on Days 1–21, followed by a 7-day break. Method of Intake: Capsules must be swallowed whole with water. They should not be crushed, opened, or chewed. Timing: Can be taken with or without food, but should be taken at the same time every day to maintain consistent blood levels. Renal Monitoring: Since Lenalidomide is primarily excreted by the kidneys, dosage adjustments are vital for patients with impaired renal function. Safety Profile and Side Effect Management Clinical management of Lenmid 25mg involves proactive monitoring of the following: 1. Hematological Support Common side effects include neutropenia (low white blood cells) and thrombocytopenia (low platelets). Regular Complete Blood Counts (CBC) are mandatory. If counts drop significantly, a dose reduction or temporary treatment interruption is standard practice. 2. Thromboembolism Prophylaxis Patients taking Lenmid have an increased risk of venous thromboembolism (blood clots). Standard care involves prescribing prophylactic anticoagulants (like aspirin or heparin) concurrently with the medication. 3. Embryo-Fetal Toxicity (REMS) Lenalidomide is structurally related to thalidomide and is a known teratogen. Strict adherence to pregnancy prevention programs (REMS) is mandatory for all patients of reproductive potential. 4. General Side Effects Patients may report fatigue, diarrhea, muscle cramps, or skin rashes. These are typically managed through adequate hydration, supportive care, and symptomatic medication. Storage and Handling Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F). Security: Keep in the original blister pack to protect from light and moisture. Handling: Caregivers should handle capsules with care and avoid direct skin contact with the powder inside Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383

Pomide 4mg Capsule (Pomalidomide): Advanced Immunomodulatory Therapy for Multiple Myeloma Pomide 4mg Capsule is a high-potency anti-cancer medication featuring the active pharmaceutical ingredient Pomalidomide. It is a third-generation immunomodulatory imide drug (IMiD) specifically engineered to treat patients with relapsed or refractory Multiple Myeloma. Manufactured by Cipla Ltd., a global leader in pharmaceuticals, Pomide 4mg offers a vital therapeutic option for patients who have already undergone multiple lines of treatment, providing a targeted approach to inhibiting tumor growth and boosting the body's natural defenses. Therapeutic Indications and Clinical Usage Pomide 4mg is extensively utilized across international oncology protocols for: Relapsed and Refractory Multiple Myeloma (RRMM): Indicated for adult patients who have received at least two prior therapies, including both Lenalidomide and a proteasome inhibitor (such as Bortezomib), and have demonstrated disease progression. Combination Therapy: For maximum clinical efficacy, Pomide is typically administered in combination with low-dose Dexamethasone. Kaposi Sarcoma (KS): In certain regulatory environments, it is also used for adult patients with AIDS-related Kaposi Sarcoma after failure of highly active antiretroviral therapy (HAART). The Mechanism: How Pomide 4mg Works The active molecule, Pomalidomide, exerts its anti-cancer effects through a sophisticated multi-pathway mechanism: Tumor Cell Inhibition: It directly binds to the protein Cereblon, part of an E3 ubiquitin ligase complex. This leads to the degradation of essential transcription factors, triggering apoptosis (programmed cell death) in malignant cells. Immune System Modulation: It enhances the activity of T-cells and Natural Killer (NK) cells, significantly increasing the body's innate ability to identify and destroy cancerous cells. Anti-Angiogenesis: It blocks the formation of new blood vessels that tumors rely on for nourishment and growth, effectively “starving“ the malignant cells. Cytokine Regulation: It inhibits the production of pro-inflammatory cytokines like TNF-$alpha$ and IL-6, which are known to fuel the proliferation of myeloma cells in the bone marrow. Dosage and Administration Guidelines Cycle-Based Dosing: The standard dose is 4 mg orally once daily on Days 1–21 of repeated 28-day cycles. Administration: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed. Timing: It can be taken with or without food but should be taken at the same time each day to maintain steady therapeutic levels. Renal/Hepatic Adjustment: Dosage adjustments may be necessary for patients with impaired renal or hepatic function, as determined by a specialist. Safety Profile and Side Effect Management Clinical management of Pomide 4 mg requires vigilant professional oversight: Hematological Monitoring: The most frequent side effects include neutropenia (low white blood cell count), anemia, and thrombocytopenia. Regular Complete Blood Counts (CBC) are mandatory. Venous Thromboembolism (VTE): There is a significantly increased risk of blood clots. Patients are often prescribed prophylactic anticoagulants (like aspirin or heparin) concurrently. Embryo-Fetal Toxicity (REMS): Pomalidomide is a known teratogen. Strict adherence to pregnancy prevention programs is mandatory for all patients of reproductive potential. General Effects: Patients may experience fatigue, constipation, diarrhea, or shortness of breath, which are usually managed with supportive care. Storage and Handling Temperature: Store at room temperature, 20°C to 25°C. Security: Keep in the original blister pack to protect from light and moisture. Safety: Caregivers should avoid direct skin contact with the capsules to prevent accidental exposure to the active powder. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Pomcad 4 mg Capsule: Understanding Pomalidomide for Multiple Myeloma Treatment Description: Learn about Pomcad 4 mg Capsule (Pomalidomide). Discover its role in treating relapsed and refractory multiple myeloma, including clinical indications, dosing, and safety precautions. Pomcad 4mg Capsule: Essential Insights into Pomalidomide Therapy for Multiple Myeloma Product Profile: Understanding Pomcad 4mg Capsule Pomcad 4mg Capsule contains Pomalidomide, an immunomodulatory agent used primarily in the treatment of multiple myeloma. It is typically prescribed for patients who have previously undergone at least two lines of therapy, including lenalidomide and a proteasome inhibitor, and whose disease has progressed. 1. Clinical Indications & Usage Relapsed/Refractory Multiple Myeloma: Used in combination with dexamethasone for adults whose cancer has not responded to or has worsened after previous standard treatments. Kaposi Sarcoma: Indicated for the treatment of adult patients with AIDS-related Kaposi sarcoma who have failed highly active antiretroviral therapy (HAART), as well as for those with HIV-negative Kaposi sarcoma. 2. Mechanism of Action Immunomodulation: Enhances the body’s immune system response to better identify and destroy malignant plasma cells. Direct Anti-Tumor Activity: Directly inhibits the proliferation of myeloma cells, disrupting their growth cycle. Anti-Angiogenic Effect: Suppresses the development of new blood vessels that tumors require for growth and survival. Bone Marrow Microenvironment: Reduces inflammation within the bone marrow, creating an environment that inhibits cancer cell survival. 3. Administration and Dosing Guide Dosage: The standard dose for multiple myeloma is 4mg taken orally once daily. Cycle: Treatment is typically administered on days 1 through 21 of a 28-day cycle, repeated as directed by your physician. Administration: The capsule should be swallowed whole with water. Do not break, chew, or crush it. It can be taken with or without food, but should be taken at the same time each day. Missing a Dose: If a dose is missed, take it as soon as possible, provided it is not almost time for your next dose. Do not double the dose. ⚠️ Safety, Side Effects, and Monitoring Common Side Effects: Fatigue, nausea, diarrhea, constipation, fever, and decreased appetite. Hematologic Monitoring: Regular blood tests are essential to monitor for low white blood cell counts, anemia, and low platelet counts, which may increase infection and bleeding risks. Thromboembolism: There is an increased risk of blood clots. Healthcare providers may prescribe prophylactic blood-thinning medications. Skin Sensitivities: Patients may experience increased skin sensitivity to sunlight. 📦 Storage and Handling Specifications Temperature: Store in a closed container at room temperature (below 30°C). Protection: Keep away from moisture, heat, and direct light. Safety: Keep out of reach of children. If a capsule is accidentally broken or opened, avoid direct skin contact. 📄 Regulatory and Compliance Documentation Restricted Distribution Certification. Regulatory Compliance WHY CHOOSE ERNEST ONCOLOGY? Global Distribution Excellence Quality & Integrity Specialized Logistics PRESCRIPTION MEDICINE IS : YES Disclaimer: This product is a strictly regulated prescription medication and must be used under the direct supervision of a licensed oncologist or healthcare professional. This content is provided for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. 📞 Contact Ernest Oncology — Pharmaceuticals Medicine Exporter (Group of Ernest Pharmaceutical Pvt. Ltd.) 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Order Here: https://wa.me/919359902383

Glioz 20mg (Temozolomide) Capsule Glioz 20mg Capsule contains Temozolomide, an oral chemotherapy medicine used in the treatment of certain types of brain tumors. It belongs to the class of medicines known as alkylating agents, which work by damaging the DNA of cancer cells and preventing them from growing and multiplying. Temozolomide capsules are commonly prescribed in oncology treatment protocols and should be taken only under the supervision of a qualified healthcare professional. Ernest Oncology supplies Glioz 20mg (Temozolomide) Capsules globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Glioz Capsule Generic Name: Temozolomide Strength: 20mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Alkylating Agent Packaging Type: Capsule Strip / Bottle Route of Administration: Oral Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Glioz 20mg Capsule Glioz (Temozolomide) Capsules are used in the treatment of: • Glioblastoma Multiforme (GBM) • Anaplastic Astrocytoma • Other malignant brain tumors It is often used in combination with radiation therapy or other cancer treatments to improve patient outcomes. How Glioz Capsule Works Temozolomide works by damaging the DNA of cancer cells, preventing them from dividing and multiplying. This helps slow the growth of tumors and supports cancer treatment. Administration Glioz 20mg Capsule should be taken: • As prescribed by a qualified healthcare professional • Usually once daily • On an empty stomach • Swallowed whole with water Dosage and duration depend on the patient’s condition and treatment protocol. Possible Side Effects Some patients may experience: • Nausea and vomiting • Fatigue • Loss of appetite • Constipation • Low blood cell counts • Increased risk of infection Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from moisture and sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Glioz 250mg (Temozolomide) Capsule Glioz 250mg Capsule contains Temozolomide, an oral chemotherapy medicine used in the treatment of certain types of brain tumors. It belongs to the class of medicines known as alkylating agents, which work by damaging the DNA of cancer cells and preventing them from growing and dividing. Temozolomide capsules are commonly prescribed as part of brain cancer treatment protocols and should only be taken under the supervision of a qualified healthcare professional. Ernest Oncology supplies Glioz 250mg (Temozolomide) Capsules worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Glioz Capsule Generic Name: Temozolomide Strength: 250mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Alkylating Agent Packaging Type: Capsule Strip / Bottle Route of Administration: Oral Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Glioz 250mg Capsule Glioz (Temozolomide) Capsules are used in the treatment of: • Glioblastoma Multiforme (GBM) • Anaplastic Astrocytoma • Other malignant brain tumors It is often used in combination with radiation therapy or other treatments to improve outcomes in brain tumor management. How Glioz Capsule Works Temozolomide works by alkylating the DNA of cancer cells, which damages their genetic material and prevents them from multiplying. This helps slow the growth of tumors and supports cancer treatment. Administration Glioz 250mg Capsule should be taken: • As prescribed by a qualified healthcare professional • Usually once daily • On an empty stomach • Swallowed whole with water Dosage and treatment duration depend on the patient’s condition and treatment protocol. Possible Side Effects Some patients may experience: • Nausea and vomiting • Fatigue • Loss of appetite • Constipation • Low blood cell counts • Increased risk of infection Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from moisture and sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Thalidomide 100mg Capsule: Immunomodulatory and Anti-Angiogenic Therapy for Multiple Myeloma and ENL Are you searching for a reliable Thalidomide 100mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted immunomodulatory agents. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Thalidomide 100mg? Thalidomide 100mg is an oral therapeutic agent containing the active pharmaceutical ingredient Thalidomide. Once known primarily for other uses, it has been repurposed as a powerful Immunomodulatory Drug (IMiD). It is a cornerstone in the treatment of plasma cell dyscrasias and specific inflammatory conditions. Due to its potent nature, it is distributed under strict regulatory oversight to ensure patient safety and therapeutic efficacy. 1. Therapeutic Indications Multiple Myeloma: Used in combination with Dexamethasone for patients with newly diagnosed multiple myeloma. It is also utilized in relapsed or refractory cases. Erythema Nodosum Leprosum (ENL): An essential treatment for the cutaneous manifestations of moderate to severe ENL (a complication of leprosy). It is also used as maintenance therapy to prevent and limit the recurrence of skin lesions. Off-Label Oncology Use: Occasionally utilized in research-backed protocols for specific solid tumors and myelodysplastic syndromes where anti-angiogenic properties are required. 2. Mechanism of Action: Multi-Faceted Attack Immunomodulation: It alters the production of cytokines, specifically inhibiting Tumor Necrosis Factor-alpha (TNF-α), which is a key driver of inflammation and cancer cell survival. Anti-Angiogenesis: It blocks the formation of new blood vessels (angiogenesis) by interfering with growth factors like VEGF and bFGF. This effectively “starves“ tumors of the nutrients needed to expand. Direct Anti-Tumor Effect: It induces cell cycle arrest and apoptosis (programmed cell death) in malignant plasma cells by disrupting their interaction with the bone marrow microenvironment. 3. Administration and Dosing Management Standard Dosing: For Multiple Myeloma, the typical dose ranges from 100mg to 200mg daily. For ENL, dosing is adjusted based on the severity of the reaction. Timing: It is generally recommended to take the capsule once daily at bedtime, at least 1 hour after the evening meal, to minimize sedation. Safety Handling: Capsules must be swallowed whole. Healthcare providers and caregivers should handle the medication with caution; direct contact with the powder inside the capsule should be avoided. Clinical Side Effects & Safety Monitoring eratogenicity (Birth Defects): This is the most critical risk. Thalidomide must never be used by pregnant women. Male and female patients must strictly adhere to specialized Risk Evaluation and Mitigation Strategies (REMS). Peripheral Neuropathy: Potential for tingling, numbness, or pain in the hands and feet. Early detection is vital to prevent permanent nerve damage. Venous Thromboembolism (VTE): Increased risk of blood clots (DVT or Pulmonary Embolism), especially when combined with steroids. Prophylactic blood thinners are often prescribed. Drowsiness & Sedation: Patients are advised to avoid heavy machinery or driving until their reaction to the drug is known. Why Source Thalidomide 100mg from Ernest Oncology? Verified Authenticity: Direct sourcing of high-integrity Thalidomide with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Lynide 5mg Capsule (Lenalidomide): Precision Immunomodulatory Therapy for Oncology Care Lynide 5mg Capsule is a high-efficacy oral antineoplastic and immunomodulatory medication containing the active pharmaceutical ingredient Lenalidomide. Manufactured by Glenmark Pharmaceuticals, a globally recognized leader in high-quality medicine, Lynide belongs to the class of drugs known as Immunomodulatory Imide Drugs (IMiDs). The 5mg strength is a vital dosage form used extensively for maintenance therapy, precise dose titration, and the management of chronic hematological malignancies. Therapeutic Indications and Clinical Usage Lynide 5mg is integrated into international oncology protocols for the management of several complex conditions: Multiple Myeloma (MM) Maintenance: Used as a long-term strategy following an autologous stem cell transplant (ASCT) to prolong progression-free survival and prevent disease relapse. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma (FL): Administered in combination with rituximab for previously treated adult patients with follicular or marginal zone lymphoma. Mechanism of Action: How Lynide 5mg Works Lynide exerts a multi-pathway biological effect to combat malignant cells while enhancing the body's natural defenses: Cereblon Binding: It binds to the protein Cereblon, part of the E3 ubiquitin ligase complex. This leads to the targeted degradation of essential transcription factors that malignant cells rely on for survival. Immune System Activation: It stimulates the proliferation and activity of T-cells and Natural Killer (NK) cells, significantly increasing the body's innate ability to identify and eliminate tumor cells. Anti-Angiogenesis: It inhibits the development of new blood vessels (angiogenesis) that tumors require for oxygen and nutrient supply. Cytokine Regulation: It suppresses the production of pro-inflammatory cytokines such as TNF-α and IL-6, which are known to promote the growth of myeloma cells in the bone marrow microenvironment. Dosage and Administration Guidelines Administration: Lynide 5 mg is an oral medication. Capsules must be swallowed whole with water. Do not open, crush, or chew the capsules. Consistency: It should be taken at approximately the same time each day, with or without food. Cycle-Based Therapy: In many maintenance protocols, it is taken daily on a 21-day or 28-day cycle. Always adhere to the specific regimen prescribed by your hematologist-oncologist. Dose Flexibility: The 5 mg strength allows clinicians to precisely adjust the dose to manage hematological toxicities or accommodate renal impairment. Safety Profile and Clinical Monitoring Due to its potent biological activity, Lynide 5 mg requires vigilant medical oversight: Hematological Monitoring: Regular Complete Blood Counts (CBC) are mandatory to monitor for neutropenia (low white blood cells) and thrombocytopenia (low platelets). Thromboembolism Risk: Lenalidomide increases the risk of blood clots. Prophylactic anticoagulation (e.g., Aspirin) is frequently prescribed concurrently. Embryo-Fetal Toxicity (REMS): Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs is mandatory for all patients, regardless of gender or age. Common Side Effects: These may include fatigue, diarrhea, muscle cramps, skin rashes, and nausea. Storage and Global Handling Instructions Temperature: Store at room temperature (20°C to 25°C). Original Packaging: Keep capsules in the original blister pack to protect them from moisture and light. Safety: Caregivers should avoid direct skin contact with the medication; if a capsule is broken, wash the area immediately with soap and water. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Mitant 12.5mg Capsule (Sunitinib): Targeted Multi-Kinase Inhibition for Advanced Oncology Mitant 12.5 mg Capsule is a high-potency oral therapeutic agent containing the active substance Sunitinib. Classified as a multi-targeted receptor tyrosine kinase (RTK) inhibitor, Mitant is a cornerstone in modern targeted cancer therapy. Manufactured by Intas Pharmaceuticals Ltd., a global leader in high-quality oncology generics, it is designed to interfere with the growth and spread of cancer cells by blocking specific signaling pathways that promote tumor angiogenesis (blood vessel formation) and cellular proliferation. Therapeutic Indications and Clinical Usage Mitant 12.5 mg is utilized globally in advanced oncology protocols for several aggressive malignancies: Renal Cell Carcinoma (RCC): Indicated for the treatment of advanced or metastatic kidney cancer, often serving as a primary first-line therapy. Gastrointestinal Stromal Tumor (GIST): Used for patients whose disease has progressed or who are intolerant to imatinib mesylate. Pancreatic Neuroendocrine Tumors (pNET): Specifically for progressive, well-differentiated pNET in patients with unresectable locally advanced or metastatic disease. Adjuvant Treatment: In specific high-risk clinical scenarios, it is used to reduce the risk of cancer returning after kidney surgery (nephrectomy). Mechanism of Action: How Mitant 12.5mg Works Anti-Angiogenesis: It inhibits receptors for Vascular Endothelial Growth Factor (VEGFR) and Platelet-Derived Growth Factor (PDGFR). By blocking these, it effectively “starves“ the tumor by preventing the development of the new blood vessels it needs to grow. Proliferation Blockade: It targets various other receptor tyrosine kinases (such as KIT and FLT3) that drive the rapid, uncontrolled division of malignant cells. Metastasis Inhibition: By disrupting these vital signaling pathways, Mitant helps limit the cancer's ability to invade surrounding tissues or migrate to distant organs. Dosage and Administration Guidelines Administration: Mitant 12.5 mg is an oral medication. Capsules must be swallowed whole with water; do not crush or chew. Standard Regimen (RCC/GIST): Typically involves a cycle of 4 weeks on treatment followed by 2 weeks off (the 4/2 schedule). Continuous Regimen (pNET): Often prescribed as a continuous daily dose without a rest period. Flexibility: The 12.5 mg strength allows for precise dose titration (e.g., reaching 25 mg, 37.5 mg, or 50 mg) based on the patient’s clinical response and tolerance levels. Food Interaction: It can be taken with or without food but should be taken at a consistent time each day to maintain steady-state plasma concentrations. Safety Profile and Clinical Monitoring Treatment with Mitant 12.5 mg requires vigilant medical oversight for: Cardiovascular Monitoring: Regular blood pressure checks are essential, as Sunitinib can cause hypertension. Hematological Vigilance: Periodic Complete Blood Counts (CBC) are necessary to monitor for neutropenia or thrombocytopenia. Thyroid Function: Monitoring for hypothyroidism is required, as this is a common side effect of TKI therapy. Liver & Heart Health: Periodic blood tests to check liver enzymes and heart function (LVEF) are standard during treatment. Skin Changes: Patients may experience skin discoloration (yellowing) or hair depigmentation during the treatment cycle. Storage and Handling Instructions Temperature: Store at controlled room temperature, 20°C to 25°C. Protection: Keep capsules in their original container to protect them from moisture and light. Safety: Ensure the medication is kept out of reach of children and handled only by the patient or a trained caregiver. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Sunitcap 25mg Capsule: Advanced Multi-Targeted Tyrosine Kinase Inhibition for Global Oncology Sourcing Are you searching for a verified Sunitcap 25mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted therapies. We facilitate a secure, high-standard supply chain for London & the UK, the USA, Australia, and South Africa, ensuring that critical tyrosine kinase inhibitors (TKIs) reach healthcare providers with 100% pharmaceutical integrity. Detailed Product Profile: What is Sunitcap 25mg? Sunitcap 25mg is an oral, multi-targeted Tyrosine Kinase Inhibitor (TKI) containing the active pharmaceutical ingredient Sunitinib Malate. Manufactured by Allieva, this 25mg strength is a specialized formulation designed to target the specific proteins that cancer cells use to grow, divide, and develop the blood vessels they need to survive. 1. Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): A first-line therapy for advanced or metastatic kidney cancer. Gastrointestinal Stromal Tumors (GIST): Specifically for patients whose disease has progressed on or who are intolerant to imatinib mesylate. Pancreatic Neuroendocrine Tumors (pNET): Used for progressive, well-differentiated tumors in patients with unresectable, locally advanced, or metastatic disease. Adjuvant Treatment: In certain high-risk settings, it is used to reduce the risk of cancer returning after nephrectomy (kidney surgery). 2. Mechanism of Action: The Dual-Action Blockade Anti-Angiogenesis: It blocks the Vascular Endothelial Growth Factor Receptors (VEGFR) and Platelet-Derived Growth Factor Receptors (PDGFR). This effectively “starves“ the tumor by preventing it from forming the new blood vessels required for nutrient delivery. Direct Anti-Tumor Activity: It inhibits KIT (CD117), RET, and FLT3, which are signaling proteins that drive the uncontrolled multiplication of cancer cells. This combined inhibition stops the signaling pathways, leading to tumor shrinkage and delayed disease progression. 3. Administration and Usage Dosing Schedule: Often taken in a “4 weeks on, 2 weeks off“ cycle, or as a continuous daily dose depending on the specific clinical indication. Timing: Can be taken with or without food. Consistency in daily timing is key for maintaining therapeutic blood levels. Precautions: Patients should avoid grapefruit and grapefruit juice, as they can significantly increase the drug's concentration in the blood, leading to toxicity. Clinical Side Effects & Safety Monitoring Fatigue & Asthenia: High levels of tiredness are a common clinical observation. Gastrointestinal Distress: Diarrhea, nausea, vomiting, stomatitis (mouth sores), and altered taste (dysgeusia). Dermatological Reactions: Hand-Foot Syndrome (redness, pain, or swelling on palms and soles), skin yellowing (not jaundice), or changes in hair color. Hypertension: High blood pressure is a frequent side effect and must be managed medically. Hematological: Decreased blood counts (neutropenia, thrombocytopenia); regular blood tests are mandatory. Endocrine: Hypothyroidism (underactive thyroid) is a known side effect requiring periodic thyroid function tests. Why Source Sunitcap 25mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva’s Sunitcap with full batch-specific traceability and COA. Logistics Authority: Expert handling of import regulations for London (UK), the USA, Australia, and South Africa. Wholesale Fulfillment: Competitive bulk pricing and steady inventory for hospital groups, specialty clinics, and regional distributors. Regulatory Compliance: Every shipment is accompanied by GMP certificates and complete B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: Chat on WhatsApp

Lenalieva 5mg Capsule: Precision Immunomodulatory Therapy for Global Hematology Sourcing Are you searching for a verified Lenalieva 5mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced hematology medications. We provide a secure, high-standard supply chain for London & the UK, the USA, Australia, and South Africa, ensuring that critical immunomodulatory treatments reach oncology centers with 100% pharmaceutical integrity. Detailed Product Profile: What is Lenalieva 5mg? Lenalieva 5mg is an oral targeted therapy containing the active pharmaceutical ingredient Lenalidomide. Manufactured by Allieva, this 5mg capsule belongs to a class of medications known as immunomodulatory agents (IMiDs). It is a cornerstone in the treatment of various plasma cell dyscrasias and certain blood disorders, offering a multi-pathway approach to halting cancer progression. 1. Therapeutic Indications Multiple Myeloma (MM): Used in combination with Dexamethasone for patients who have received at least one prior therapy, and as a maintenance therapy following autologous stem cell transplantation. Myelodysplastic Syndromes (MDS): Specifically for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after two prior therapies, one of which included Bortezomib. Follicular Lymphoma & Marginal Zone Lymphoma: In combination with Rituximab for previously treated adult patients. 2. Mechanism of Action: The Three-Tiered Defense Immune System Stimulation: It enhances the activation of T-cells and Natural Killer (NK) cells, significantly improving the body’s innate ability to identify and destroy malignant cells. Anti-Angiogenesis: It inhibits the growth of new blood vessels (angiogenesis) within the bone marrow, effectively “starving“ the tumor of the nutrients and oxygen it needs to expand. Direct Tumor Suppression: It binds directly to the Cereblon E3 ubiquitin ligase complex, leading to the degradation of essential transcription factors (Aiolos and Ikaros) required for the survival of B-cell malignancies. 3. Administration and Dosing Cycle Management: Often prescribed in a 28-day cycle (e.g., 21 days on, 7 days off). Timing: The capsule should be taken at approximately the same time each day, with or without food. Handling: Capsules must be swallowed whole. They should not be opened, broken, or chewed. Clinical Side Effects & Safety Monitoring Hematological Toxicity: Significant risk of Neutropenia (low white blood cells) and Thrombocytopenia (low platelets). Weekly blood counts are typically required during the first several cycles. Venous Thromboembolism: Increased risk of deep vein thrombosis (DVT) and pulmonary embolism. Prophylactic anticoagulation is often recommended. Teratogenicity: CRITICAL WARNING: Lenalidomide is structurally related to thalidomide and can cause severe, life-threatening birth defects. Strict adherence to a regulated pregnancy prevention program is mandatory. Gastrointestinal: Diarrhea, constipation, nausea, and abdominal pain. General: Fatigue, muscle cramps, and skin rashes. Why Source Lenalieva 5mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva’s Lenalieva with full batch-specific traceability and COA. Logistics Authority: Expert handling of complex import regulations for London (UK), the USA, Australia, and South Africa. Bulk Supply Solutions: Competitive wholesale pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment is accompanied by GMP certificates and comprehensive B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: Chat on WhatsApp

Nindalieva 150mg Capsule: Advanced Tyrosine Kinase Inhibition for Pulmonary and Oncology Management Are you searching for a reliable Nindalieva 150mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced antifibrotic and antineoplastic therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Nindalieva 150mg? Nindalieva 150mg is an oral targeted therapy containing the active pharmaceutical ingredient Nintedanib. Manufactured by Allieva Pharma Pvt Ltd, this 150mg capsule is a potent small-molecule tyrosine kinase inhibitor (TKI). It is specifically engineered to block pathways involved in the progression of pulmonary fibrosis and the growth of specific types of lung tumors, making it a cornerstone in respiratory and oncology care. 1. Therapeutic Indications Idiopathic Pulmonary Fibrosis (IPF): Used to slow the decline in lung function in patients with chronic, progressive scarring of lung tissue. Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Indicated to slow the rate of decline in pulmonary function in patients with connective tissue disease-related lung involvement. Progressive Fibrosing Interstitial Lung Diseases (ILDs): For patients with a chronic fibrosing phenotype that continues to worsen despite treatment. Non-Small Cell Lung Cancer (NSCLC): In specific global regions, it is used in combination with Docetaxel for the treatment of advanced adenocarcinoma after first-line chemotherapy. 2. Mechanism of Action: Triple Kinase Inhibition Inhibition of Pro-Fibrotic Pathways: It targets Platelet-Derived Growth Factor Receptors (PDGFR), Fibroblast Growth Factor Receptors (FGFR), and Vascular Endothelial Growth Factor Receptors (VEGFR). Blocking Fibroblast Proliferation: By inhibiting these signaling pathways, it prevents the migration and transformation of fibroblasts, which are the primary cells responsible for lung scarring. Anti-Angiogenic Effect: In oncology, it interferes with the tumor’s ability to develop new blood vessels, effectively limiting the supply of nutrients required for tumor expansion. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is 150mg taken twice daily, approximately 12 hours apart. Administration: Capsules must be swallowed whole with food and a full glass of water. They should not be crushed or chewed due to the bitter taste and potential for irritation. Missed Dose: If a dose is missed, the patient should skip it and take the next dose at the scheduled time; double doses should be avoided. Clinical Side Effects & Safety Monitoring Gastrointestinal Health: Diarrhea and nausea are very common; hydration and anti-diarrheal management are often necessary. Hepatotoxicity: Drug-induced liver injury is a risk; Liver Function Tests (LFTs) must be conducted before starting and periodically during treatment. Cardiovascular Risks: Monitoring for arterial thromboembolic events (such as myocardial infarction) and hypertension. Pregnancy Warning: Nintedanib can cause fetal harm; effective contraception is mandatory for female patients of reproductive potential. Why Source Nindalieva 150mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Nindalieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Pomalid 4mg Capsule: Understanding Pomalidomide for Multiple Myeloma Description: Discover comprehensive information about Pomalid 4mg Capsule (Pomalidomide). Learn about its clinical uses in multiple myeloma, mechanism of action, dosing guidelines, and vital safety precautions for patients. Pomalid 4mg Capsule: Essential Insights into Pomalidomide Therapy for Blood Cancer. Product Profile: Understanding Pomalid 4mg Capsule Pomalid 4mg Capsule (Pomalidomide) is a potent immunomodulatory medication primarily used to treat multiple myeloma, a cancer of the plasma cells in the bone marrow. It is often prescribed for patients who have previously undergone multiple lines of therapy and whose disease has continued to progress. 1. Clinical Indications & Usage Relapsed/Refractory Multiple Myeloma: Treatment for adult patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have shown disease progression. Combination Therapy: It is typically administered in combination with dexamethasone to enhance its therapeutic effectiveness. 2. Mechanism of Action Immune Activation: Enhances the proliferation and functional capacity of T-lymphocytes and Natural Killer (NK) cells to target cancer cells. Angiogenesis Inhibition: Obstructs the formation of new blood vessels required by tumor cells to grow and survive. Induction of Apoptosis: Initiates programmed cell death within myeloma cells to reduce tumor bulk. Cytokine Modulation: Regulates the synthesis of key cytokines to disrupt the immunosuppressive environment created by malignancies. 3. Administration and Dosing Guide Standard Dose: The recommended dose is 4 mg taken orally once daily. Cycle: Treatment is typically administered on Days 1 through 21 of repeated 28-day cycles. Consistency: Take the capsule at the same time each day, either with or without food. Missed Doses: If a dose is missed, it may be taken within 12 hours of the scheduled time. If more than 12 hours have passed, skip the missed dose and resume your regular schedule. Never double the dose. ⚠️ Safety, Side Effects, and Monitoring Common Side Effects: Fatigue, nausea, diarrhea, constipation, fever, and coughing. Hematologic Monitoring: Regular blood tests are critical to monitor for neutropenia (low white blood cell count) and thrombocytopenia (low platelet count), which increase the risk of infection and bleeding. Blood Clot Risk: There is an increased risk of thromboembolic events (e.g., deep vein thrombosis or pulmonary embolism). Pregnancy Warning: Pomalidomide is strictly contraindicated during pregnancy due to the risk of severe birth defects. Both male and female patients must use effective contraception as directed by their physician. 📦 Storage and Handling Specifications Temperature: Store in a cool, dry place at or below 30°C. Protection: Keep the container tightly closed and protect it from direct sunlight and moisture. Safety Handling: If the capsule is accidentally opened or broken, avoid direct skin contact. If contact occurs, wash the area thoroughly with soap and water. Disposal: Keep out of reach of children and pets. 📄 Regulatory and Compliance Documentation Safety Programs Quality Verification Professional Distribution WHY CHOOSE ERNEST ONCOLOGY? Global Reach & Reliability Quality Assurance Specialized Logistics PRESCRIPTION MEDICINE IS :YES Disclaimer: This product is a strictly regulated prescription drug and must be administered under the supervision of a licensed oncologist or healthcare professional. This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult your physician for medical guidance. 📞 Contact Ernest Oncology —Pharmaceutical Medicine Exporter (Group of Ernest Pharmaceutical Pvt. Ltd.) 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Order Here: https://wa.me/919359902383

Pomalid 4mg Capsules: Targeted Therapy for Multiple Myeloma Description: Discover essential information on Pomalid 4mg capsules. Learn about its use in multiple myeloma, administration, safety protocols, and how to source high-quality oncology medications through Ernest Oncology. Headline: Pomalid 4mg Capsules: Clinical Insights and Patient Safety Guidelines Understanding Pomalid 4mg Capsules Pomalid 4mg capsules are a specialized immunomodulatory medication primarily indicated for the treatment of Multiple Myeloma, a cancer of the plasma cells in the bone marrow. This therapy is often prescribed in combination with other agents, such as dexamethasone, to help manage the disease by targeting abnormal cells and supporting the body’s natural immune response. 1. Clinical Indications & Usage Pomalid is indicated for patients who have previously received other standard treatments for multiple myeloma, including lenalidomide and a proteasome inhibitor, and whose disease has demonstrated progression during or within 60 days of completing the last therapy. It is an oral medication designed to stabilize the condition and extend progression-free survival. 2. Mechanism of Action Targeted Degradation: It binds to the cereblon (CRBN) protein, triggering the ubiquitination and degradation of specific transcription factors (Ikaros and Aiolos) essential for myeloma cell survival. Immune System Activation: It enhances the proliferation and activation of T-cells and Natural Killer (NK) cells to better identify and eliminate malignant cells. Anti-Angiogenic Activity: It inhibits the formation of new blood vessels that provide the necessary nutrients and oxygen for tumor growth. Induction of Apoptosis: It initiates programmed cell death within myeloma cells and disrupts the protective interactions between these cells and the bone marrow microenvironment. 3. Administration and Dosing Guide Dosage: The standard dose is 4 mg taken orally once daily. Cycle: It is typically administered on Days 1 to 21 of each 28-day cycle. Instructions: Capsules should be swallowed whole with water. They may be taken with or without food but should be taken at the same time each day to maintain consistent blood levels. Missed Doses: If a dose is missed, patients should not take two doses at once; they should wait until their next scheduled time. ⚠️ Safety, Side Effects, and Monitoring Common Side Effects: Fatigue, nausea, diarrhea, constipation, back pain, and decreased appetite. Blood Cell Impacts: Pomalid may lower white blood cell, red blood cell, and platelet counts, increasing the risk of infections, anemia, and bruising. Regular blood counts are essential. Severe Risks: It carries significant risks for fetal harm; therefore, strict pregnancy prevention programs must be followed by both men and women. There is also a risk of blood clots (venous thromboembolism). Monitoring: Regular medical check-ups, blood tests (for blood count and liver/kidney function), and monitoring for signs of infection or respiratory issues are vital. 📦 Storage and Handling Specifications Temperature: Store at controlled room temperature (typically 20°C to 25°C). Safety: Keep out of reach of children and pets. Store in a secure, dry place. Handling: Because the drug can be absorbed through the skin, capsules should not be opened, crushed, or broken. If a capsule is damaged, avoid inhaling the powder and wash the area thoroughly with soap and water. 📄 Regulatory and Compliance Documentation GMP Certification International Standards Import Compliance Pharmacovigilance WHY CHOOSE ERNEST ONCOLOGY? Global Reliability Quality Assurance Dedicated Logistics PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Pomalidomide is a prescription medication that must only be used under the strict supervision of a qualified oncologist or healthcare professional. Always consult your doctor before starting any new medication. Use of this drug requires adherence to a mandatory pregnancy prevention program. Contact Ernest Oncology—Pharmaceutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Lenalid 25mg Capsules: Understanding Targeted Therapy for Oncology Description: Explore key information on Lenalid 25 mg capsules, including clinical indications, dosing, safety, and supply options. Learn how Ernest Oncology supports global access to essential cancer treatments. Lenalid 25mg Capsules: Comprehensive Patient Information and Treatment Guidance Product Profile: Understanding Lenalid 25mg Capsules Lenalid 25mg (Lenalidomide) is a potent immunomodulatory medication utilized primarily in the management of specific hematological malignancies. It acts as both a targeted therapy and an immune-system modulator to assist the body in identifying and controlling abnormal cell growth. 1. Clinical Indications & Usage Multiple Myeloma: Often used in combination with dexamethasone for adult patients and as maintenance therapy following a stem cell transplant. Mantle Cell Lymphoma (MCL): Indicated for patients who have relapsed or progressed after previous therapies. Myelodysplastic Syndromes (MDS): Used for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Lymphoma variants: Used in combination therapy for previously treated Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL). 2. Mechanism of Action Ubiquitin Ligase Modulation: Binds to the CRBN protein, modulating the substrate specificity of the E3 ubiquitin ligase complex. Targeted Degradation: Triggers the proteasomal degradation of specific transcription factors (IKZF1 and IKZF3) critical for the survival of malignant plasma cells. Angiogenesis Inhibition: Blocks the development of new blood vessels that tumors require to grow and spread. Immune Activation: Enhances the body’s natural immune response by stimulating T-cells and Natural Killer (NK) cells to target and destroy cancer cells. 3. Administration and Dosing Guide Routine: Capsules are taken orally once daily, ideally at the same time each day, with a full glass of water. Food Intake: Can be taken with or without food. Handling: Capsules must be swallowed whole. Do not break, crush, chew, or open them. Consistency: Follow your physician’s specific cycle instructions (e.g., Days 1–21 of a 28-day cycle) precisely. ⚠️ Safety, Side Effects, and Monitoring Severe Risks: Significant risk of embryo-fetal toxicity (severe birth defects). Strict adherence to pregnancy prevention programs is mandatory. Hematologic Effects: Can cause significant neutropenia (low white blood cells) and thrombocytopenia (low platelets). Frequent blood tests are required to monitor blood counts. Common Reactions: Fatigue, diarrhea, constipation, rash, muscle cramps, and respiratory infections are frequently reported. 📦 Storage and Handling Specifications Environment: Store at controlled room temperature (20°C to 25°C). Keep in a dry, secure place away from heat, light, and moisture. Security: Keep strictly out of reach of children. Handling Precautions: If a capsule is damaged, avoid inhaling the powder. Wash hands thoroughly after any potential contact. Safe Disposal: Never share medication. Dispose of unused capsules according to local medical waste regulations or consult your pharmacist. 📄 Regulatory and Compliance Documentation Quality Certification: All products sourced from facilities adhering to strict WHO-GMP and international pharmaceutical quality standards. Batch Integrity: Each batch is subjected to comprehensive testing to confirm purity, potency, and stability before export. Documentation Support: Comprehensive documentation (COA, MOA, and regulatory dossiers) is provided to facilitate smooth customs and import compliance. WHY CHOOSE ERNEST ONCOLOGY? Global Supply Expertise Commitment to Quality Customer-Centric Service PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Lenalidomide is a high-risk prescription medication that must be used strictly under the guidance of a licensed oncologist or healthcare professional. It is associated with severe birth defects and requires strict adherence to mandatory safety and pregnancy prevention programs. Contact Ernest Oncology—Pharmaceutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Lenalid 15mg Capsules: Clinical Insights and Patient Safety Guidelines Description: Discover essential information on Lenalid 15 mg capsules for the treatment of multiple myeloma and lymphoma. Learn about its mechanism, administration, and how to source high-quality oncology medications via Ernest Oncology. Lenalid 15mg Capsules: Clinical Insights and Patient Safety Guidelines Product Profile: Understanding Lenalid 15mg Capsules Lenalid 15mg (Lenalidomide) is a specialized immunomodulatory medication indicated for the management of various hematological malignancies. It acts by modulating the immune system and inhibiting processes that allow cancer cells to proliferate, making it a cornerstone treatment for patients battling multiple myeloma, myelodysplastic syndromes (MDS), and specific types of lymphoma. 1. Clinical Indications & Usage Multiple Myeloma: Often used in combination with other therapeutic agents to stabilize the disease and support patient recovery. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Used for patients who have relapsed or progressed after previous standard treatment lines. Follicular and Marginal Zone Lymphoma: Utilized in combination regimens to improve outcomes in previously treated patients. 2. Mechanism of Action E3 Ubiquitin Ligase Modulation: Binds to the CRBN protein, altering the substrate specificity of the E3 ubiquitin ligase complex. Proteasomal Degradation: Triggers the rapid degradation of key transcription factors (IKZF1 and IKZF3) necessary for malignant cell survival. Angiogenesis Inhibition: Suppresses the development of new blood vessels that provide essential nutrients to tumor growths. 3. Administration and Dosing Guide Consistency: Take your capsule at the same time every day to maintain steady blood levels. Intake: Swallow the capsule whole with a full glass of water. Do not crush, chew, or open the capsule, as the contents can be harmful if they touch the skin. Flexibility: It can be taken with or without food. Cycle Adherence: Follow the exact cycle schedule (e.g., Days 1–21 of a 28-day cycle) as prescribed by your oncologist. If you miss a dose, consult your healthcare provider rather than taking an extra capsule. ⚠️ Safety, Side Effects, and Monitoring Pregnancy Warning: This medication is structurally related to thalidomide and can cause severe, life-threatening birth defects. A strict pregnancy prevention program is mandatory. Blood Cell Monitoring: Lenalidomide can lower blood cell counts, increasing the risk of infection, anemia, or bruising. Regular complete blood count (CBC) tests are essential. Common Side Effects: Fatigue, diarrhea, rash, and muscle cramps are common. Report any persistent or severe symptoms, such as fever or dizziness, to your medical team. 📦 Storage and Handling Specifications Storage: Keep at a controlled room temperature (20°C to 25°C) in a dry, dark place. Security: Store in a secure location completely out of the reach of children and pets. Handling: Direct contact with the capsule powder must be avoided. If a capsule is damaged, avoid inhaling the powder and wash affected skin areas thoroughly with soap and water. Disposal: Do not share this medicine. Return any unused capsules to your pharmacy or dispose of them according to local hazardous medical waste protocols. 📄 Regulatory and Compliance Documentation GMP Certified: All medications are sourced from facilities that strictly adhere to World Health Organization Good Manufacturing Practices. Comprehensive Documentation: Every shipment is accompanied by a Certificate of Analysis (COA) and Method of Analysis (MOA) to verify purity and potency. Export Verification: Our processes include all necessary regulatory documentation required for health authority clearance in the USA, UK, Australia, and South Africa. WHY CHOOSE ERNEST ONCOLOGY? Global Logistics Excellence Uncompromising Quality Control Dedicated Patient-First Support PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Lenalidomide is a high-potency prescription drug that must only be used under the supervision of a qualified oncologist. It is strictly contraindicated in pregnancy due to the risk of severe birth defects. Always consult with your healthcare provider for diagnosis and treatment. Contact Ernest Oncology — Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Lenalid 10mg Capsules: Clinical Insights and Patient Safety Guidelines Description: Discover essential information on Lenalid 10mg capsules for the treatment of multiple myeloma and lymphoma. Learn about its mechanism, administration, and how to source high-quality oncology medications via Ernest Oncology. Lenalid 10mg Capsules: Clinical Insights and Patient Safety Guidelines Product Profile: Understanding Lenalid 10mg Capsules Lenalid 10mg (Lenalidomide) is a targeted immunomodulatory therapy used to treat various blood cancers. By modulating the immune system and disrupting the pathways that cancer cells use to survive and multiply, it serves as a fundamental medication for patients diagnosed with specific hematological conditions. 1. Clinical Indications & Usage Multiple Myeloma (MM): Used as maintenance therapy following an autologous hematopoietic stem cell transplant (auto-HSCT). Myelodysplastic Syndromes (MDS): Indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Used for patients whose disease has relapsed or progressed after prior therapies. Follicular and Marginal Zone Lymphoma: Used in combination with other treatments for patients who have received at least one prior systemic therapy. 2. Mechanism of Action E3 Ubiquitin Ligase Binding: Binds to the Cereblon (CRBN) protein to modulate the substrate specificity of the CRL4-CRBN E3 ubiquitin ligase complex. Angiogenesis Inhibition: Suppresses the production of vascular endothelial growth factor (VEGF), effectively starving tumors of their necessary blood supply. Immune System Activation: Stimulates the activation and proliferation of T-cells and natural killer (NK) cells to enhance anti-tumor immune responses. 3. Administration and Dosing Guide Consistency: Take the capsule orally once daily, ideally at the same time every day, to maintain consistent blood levels. Intake: Swallow the capsule whole with a full glass of water. Do not crush, break, chew, or open the capsule. Cycle Adherence: Follow the exact dosing schedule provided by your oncologist (e.g., continuous daily use or specific cycles such as Days 1–21 of a 28-day cycle). Missed Doses: If a dose is missed, do not take an extra capsule. Resume your regular schedule the following day. ⚠️ Safety, Side Effects, and Monitoring Pregnancy Warning: Lenalidomide can cause severe, life-threatening birth defects. Patients must strictly adhere to mandated pregnancy prevention programs. Blood Cell Impacts: This medication can cause neutropenia (low white blood cells) and thrombocytopenia (low platelets). Frequent monitoring via blood tests is essential. Common Side Effects: Fatigue, diarrhea, rash, and muscle cramps are common. Report any persistent or severe symptoms to your medical team. 📦 Storage and Handling Specifications Storage: Store in a secure, dry place at controlled room temperature (20°C to 25°C). Security: Keep strictly out of reach of children and pets. Handling Precautions: Avoid direct skin contact with the capsule contents. If a capsule is damaged, avoid inhaling the powder and wash affected areas thoroughly with soap and water. Disposal: Do not share this medication. Return unused capsules to your pharmacist or follow local medical waste disposal protocols. 📄 Regulatory and Compliance Documentation GMP Certified Pharmacopoeia Standards Export Documentation Global Compliance WHY CHOOSE ERNEST ONCOLOGY? Global Supply Reliability Quality Assurance Dedicated Support PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Lenalidomide is a high-potency prescription medication that must be used strictly under the guidance of a licensed oncologist. It is contraindicated in pregnancy and requires adherence to strict safety programs. Always consult your physician for diagnosis and treatment. 📞 Contact Ernest Oncology—Pharmaceutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Fenoxene 10mg Capsules: Clinical Insights and Patient Safety Guidelines Description: Discover essential information on Fenoxene 10mg (Phenoxybenzamine) capsules. Learn about its use in managing symptoms of pheochromocytoma, administration, and how to source high-quality medical supplies through Ernest Oncology. Fenoxene 10mg Capsules: Clinical Insights and Patient Safety Guidelines Product Profile: Understanding Fenoxene 10mg Capsules Fenoxene 10mg (Phenoxybenzamine) is a potent alpha-adrenergic blocking agent used primarily to manage the effects of excess catecholamines. It is specifically indicated to treat the symptoms associated with pheochromocytoma, a rare tumor of the adrenal glands, helping to control high blood pressure, sweating, and rapid heart rate. 1. Clinical Indications & Usage Pheochromocytoma Management: Used to control paroxysmal hypertension and sweating caused by the excess release of adrenaline and noradrenaline from adrenal tumors. Pre-operative Stabilization: Administered to patients prior to surgery to prevent dangerous fluctuations in blood pressure during tumor removal . Symptomatic Control: Provides long-term management for patients with metastatic or unresectable tumors to improve quality of life. 2. Mechanism of Action Alpha-Receptor Blockade: Acts as a non-selective, irreversible antagonist of alpha-adrenergic receptors. Vasodilation: Binds to alpha-receptor proteins to inhibit their action, causing relaxation and dilation of blood vessels. Hormonal Inhibition: Opposes the action of adrenaline and noradrenaline released by the tumor that would otherwise constrict vessels. Pressure Reduction: Decreases peripheral resistance, thereby lowering blood pressure and increasing blood flow to skin, mucosa, and viscera. 3. Administration and Dosing Guide Dosing: The initial dose is typically 10mg twice daily, adjusted by your healthcare provider based on your clinical response and blood pressure readings. Consistency: Take the medication at the same time each day to maintain steady therapeutic levels in the blood. Usage: Capsules should be swallowed whole with a glass of water. Do not crush, chew, or open the capsule. Consistency: It may be taken with or without food, but ensure you follow the specific instructions provided by your doctor. ⚠️ Safety, Side Effects, and Monitoring Postural Hypotension: A common risk is a sudden drop in blood pressure when standing up (orthostatic hypotension). Rise slowly from sitting or lying positions. Cardiovascular Effects: May cause a rapid or irregular heartbeat (tachycardia) as a reflex response to lowered blood pressure. Common Side Effects: Nasal congestion, fatigue, dizziness, and inhibition of ejaculation. 📦 Storage and Handling Specifications Temperature: Store at controlled room temperature (20°C to 25°C). Environment: Keep in a dry, cool place away from direct sunlight and moisture. Safety: Store securely and keep entirely out of the reach of children. Disposal: Never share this medication. Return unused or expired capsules to your pharmacist for proper medical waste disposal. 📄 Regulatory and Compliance Documentation Quality Certification International Standards Documentation Support Global Export Compliance WHY CHOOSE ERNEST ONCOLOGY? Supply Chain Reliability Stringent Quality Assurance Comprehensive Global Support PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Fenoxene (Phenoxybenzamine) is a prescription medication that must be used strictly under the supervision of a qualified physician or endocrinologist. Always consult your doctor for diagnosis and individualized treatment plans. 📞Contact Ernest Oncology — Pharmacveutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Yohimbine 5 mg Tablet – Product Information Guide: Yohimbine 5 mg Tablet | Yohimbine Tablets | Ernext Oncology Description Learn about Yohimbine 5 mg Tablet, including composition, category, safety precautions, storage, regulatory guidance, and export documentation support from Ernext Oncology. Yohimbine 5 mg Tablet Yohimbine 5 mg Tablet contains Yohimbine, an alpha-2 adrenergic antagonist medicine. It is generally used under medical supervision for selected conditions where adrenergic receptor activity may be clinically relevant. Product Profile: Understanding Yohimbine 5 mg Tablet Yohimbine 5 mg is generally supplied as an oral tablet. It belongs to the alpha-2 adrenergic antagonist / sexual wellness prescription medicine category and may be regulated differently depending on the country. Key Product Information Brand Name: Yohimbine 5 mg Generic Name: Yohimbine Strength: 5 mg Dosage Form: Tablet Therapeutic Category: Alpha-2 Adrenergic Antagonist Route of Administration: Oral Use Status: Prescription / regulated as per local rules Clinical & Regulatory Usage Note Yohimbine may be prescribed by qualified healthcare professionals for selected clinical conditions depending on approved indications and local treatment guidelines. Mechanism of Action: How Yohimbine 5 mg Works Yohimbine works mainly by blocking alpha-2 adrenergic receptors. This may influence nervous system signaling and blood flow-related pathways. Administration and Handling Guide General handling points: Use only as directed by a licensed medical professional. Do not self-medicate. Do not exceed prescribed instructions. Follow all prescription and import rules. Keep the product in original packaging. Do not use expired or damaged tablets. Safety, Side Effects, and Monitoring Yohimbine may cause side effects in some individuals, especially if misused or taken without professional supervision. Possible Side Effects Headache Dizziness Nausea Nervousness or anxiety Increased heart rate Blood pressure changes Sweating Sleep disturbance Mild stomach discomfort Precautions Not for self-medication. Not recommended without legal prescription or medical authorization. Inform a healthcare professional about heart disease, blood pressure problems, kidney disease, liver disease, anxiety disorders, or psychiatric conditions. Inform your doctor about all medicines, supplements, or herbal products currently being used. Avoid use during pregnancy or breastfeeding unless specifically advised by a qualified healthcare professional. Storage and Handling Specifications Store in a cool and dry place. Protect from direct sunlight. Keep away from heat and moisture. Keep out of reach of children. Keep tablets in original blister or container. Do not use after expiry date. Regulatory and Compliance Documentation Certificate of Analysis Batch details Product specification sheet Manufacturing information Quality documentation Commercial invoice and packing list Export documentation support Frequently Asked Questions 1. What is Yohimbine 5 mg Tablet? Yohimbine 5 mg Tablet contains Yohimbine, an alpha-2 adrenergic antagonist medicine used under medical supervision for selected clinical conditions. 2. What is the composition of Yohimbine 5 mg? The composition is Yohimbine 5 mg, depending on manufacturer specification. 3. What is the dosage form? It is supplied as an oral tablet. 4. What is the medicine category? Yohimbine 5 mg belongs to the alpha-2 adrenergic antagonist category. 5. Is Yohimbine 5 mg a prescription product? Yes. It should be treated as a prescription or regulated product depending on local rules. PRESCRIPTION MEDICINE IS: YES Disclaimer Yohimbine 5 mg is a prescription or regulated medicine in many markets. This information is for educational and export documentation purposes only. It is not medical advice. Use, sale, import, or distribution must follow applicable laws, prescription rules, and regulatory requirements. 📞C ontact Ernext Oncology - Pharmaceutical Medicine Exporter [Group of Ernest Pharmaceutical Pvt. Ltd.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | OEM Partner 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Overview of Altretamine Capsules 50mg Altretamine capsules, 50 mg, are specialized oral chemotherapy medications used in the treatment of ovarian cancer, particularly in cases where the disease has returned after initial therapy. Classified as an alkylating agent, this medicine is administered under strict medical supervision as part of a comprehensive cancer care plan. How Altretamine Works Once ingested, Altretamine undergoes metabolic conversion in the body to form active compounds. These compounds disrupt the DNA structure of cancer cells, inhibiting their ability to multiply. By targeting rapidly dividing cells, the medication helps control tumor growth and supports ongoing cancer management. Therapeutic Applications Altretamine capsules are prescribed for the following: Recurrent ovarian cancer cases Advanced-stage ovarian tumors after prior treatments Use alongside other chemotherapy drugs. Long-term cancer therapy guided by oncology specialists Administration Guidelines Dosage is customized based on patient-specific factors such as body surface area and overall health. Capsules should be taken orally with water, without crushing or chewing. Adherence to the prescribed schedule is essential for effectiveness. Any changes in dosage should only be made after consulting a healthcare professional. Frequently Asked Questions 1. What conditions are treated with Altretamine Capsules 50 mg? It is primarily used for treating ovarian cancer that has recurred after initial chemotherapy. 2. What is the correct way to take this medication? Follow your oncologist’s instructions carefully and take the capsules as prescribed. 3. Can this drug be part of combination therapy? Yes, it may be used alone or alongside other chemotherapy agents depending on the treatment plan. 4. Is international supply available? Yes, it is exported globally to authorized healthcare providers and distributors. 5. Do I need a prescription to obtain Altretamine Capsules? Yes, this medication is strictly available with a valid prescription and requires medical supervision. Administration Guidelines Dosage is customized based on patient-specific factors such as body surface area and overall health. Capsules should be taken orally with water, without crushing or chewing. Adherence to the prescribed schedule is essential for effectiveness. Any changes in dosage should only be made after consulting a healthcare professional. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383 #Altretamine #CancerTherapy #OvarianCancerTreatment #OncologyDrugs #PharmaExports #GlobalMedicineSupply #CancerCareSolutions #GenericPharma #HealthcareDistribution #BulkMedicines #IndianPharmaceuticals #GMPCertified #PharmaIndustry #MedicalExports #Oncology

Anastrozole Tablets: Oncology Medicine Supplier Medicine Highlights Generic Name: Anastrozole Strength: 1 mg Dosage Form: Film-Coated Tablets Medicine Category: Aromatase Inhibitor Administration: Oral Availability: Prescription Medicine Supply: Bulk Export | Hospital Supply | Distributor Orders Patient Advantages ✔ Once-daily oral treatment ✔ Supports long-term hormone management ✔ Suitable for outpatient therapy ✔ Widely included in breast cancer treatment protocols ✔ Available in export-quality packaging ✔ Bulk quantities available for institutional procurement Before Starting Treatment Patients should inform their healthcare provider if they have: Previous bone fractures or osteoporosis Reduced kidney function Liver disorders High cholesterol levels History of cardiovascular disease Allergic reaction to aromatase inhibitors Regular medical follow-up helps monitor treatment effectiveness and overall health. Possible Undesirable Effects Although not every patient experiences side effects, some may notice: Excessive sweating Difficulty sleeping Muscle discomfort Dryness of the skin Reduced bone mineral density Mood fluctuations Loss of energy Digestive discomfort Frequently Asked Questions Q1. Is Anastrozole used before or after surgery? It may be prescribed before or after surgery depending on the oncologist's treatment strategy. Q2. Can hospitals order Anastrozole in bulk? Yes. Bulk quantities are available for licensed hospitals and pharmaceutical distributors. Q3. Is Anastrozole suitable for long-term treatment? Many patients receive long-term therapy based on their individual treatment plan. Q4. Does this medicine require regular monitoring? Yes. Doctors may monitor bone health, cholesterol, and treatment response during therapy. Q5. Is international export available? Yes. Export supply is available for licensed pharmaceutical importers and healthcare organizations. #Anastrozole1mg #HormoneTherapyMedicine #BreastCancerAwareness #CancerCare #GenericOncology #OncologyExports #PharmaceuticalSupplier #HospitalMedicines #GlobalPharma #CancerTreatment #MedicineWholesaler #HealthcareDistribution #IndianMedicineExporter #BulkPharma #ErnestImpex 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 Anastrozole Tablets Export from India Buy Generic Anastrozole UK Aromatase Inhibitor Supplier Breast Cancer Drug Distributor Oncology Tablets Manufacturer Hospital Medicine Supplier Pharmaceutical Export Company GMP Cancer Medicine Breast Cancer Hormone Tablets Oncology Medicine Wholesaler International Pharma Export Generic Breast Cancer Medicine Bulk Anastrozole Tablets Licensed Oncology Supplier Anastrozole Procurement Company

Trusted Etoposide Injection 100mg Supplier & Global Oncology Medicine Exporter from India 📋 Product Overview Specification Details Generic Name Etoposide Strength 100 mg Dosage Form Sterile Injection Drug Class Topoisomerase II Inhibitor Therapeutic Category Oncology Medicine Route of Administration Intravenous Infusion Prescription Status Prescription Only Supply Type Bulk Supplier • Exporter • Distributor Country of Origin India 💉 About Medicine Etoposide Injection 100mg is a sterile prescription anticancer medicine used in specialized chemotherapy protocols. It belongs to the topoisomerase II inhibitor class and is administered intravenously by qualified healthcare professionals. The medicine is commonly included in individualized cancer treatment plans after careful evaluation by an oncology specialist. 🌟 Medical Benefits When prescribed by an oncology specialist, Etoposide Injection 100mg may offer several clinical benefits: Helps control the growth of rapidly dividing cancer cells. Included in combination chemotherapy regimens for selected cancers. Sterile injectable formulation designed for hospital use. Suitable for individualized oncology treatment protocols. Supports comprehensive cancer management under medical supervision. Widely used by oncology centers and tertiary-care hospitals worldwide. ⚠️ What Side Effects Can This Medication Cause? Possible side effects include: Reduced white blood cell count Increased risk of infection Nausea or vomiting Temporary hair loss Fatigue or weakness Mouth ulcers Loss of appetite Mild decrease in blood pressure during infusion Easy bruising or bleeding Temporary changes in liver function tests ❓ Frequently Asked Questions 1. What is Etoposide Injection 100mg primarily used for? Etoposide Injection 100mg is prescribed as part of selected chemotherapy treatment plans for certain cancers. Its use is determined by an oncology specialist based on the patient's diagnosis and overall treatment strategy. 2. Who should administer Etoposide Injection? This medicine should only be prepared and administered by trained healthcare professionals in hospitals or specialized oncology treatment facilities. 3. What are the most common side effects of Etoposide Injection? Some patients may experience nausea, fatigue, temporary hair loss, reduced blood cell counts, mouth sores, or an increased risk of infection. Regular medical monitoring helps manage these effects during treatment. 4. Can international healthcare buyers import Etoposide Injection 100mg? Yes. Licensed pharmaceutical importers, hospitals, government procurement agencies, and authorized distributors can source this medicine in accordance with their country's import regulations. 5. What should international buyers confirm before placing an order? Buyers should verify product strength, shelf life, packaging, batch availability, export documentation (such as COA and other applicable certificates), and destination-country regulatory requirements before procurement. Buy Etoposide Injection 100mg Online Etoposide Injection 100mg Supplier India Oncology Injection Exporter Bulk Cancer Medicine Supplier Etoposide Injection Jamaica Etoposide Injection Peru Etoposide Injection Paraguay Injectable Chemotherapy Supplier Pharmaceutical Export Company India Hospital Oncology Medicine Distributor #EtoposideInjection100mg #OncologyInjectionSupplier #CancerMedicineExporter #GlobalPharmaSupply #InjectableOncology #HospitalMedicineSupplier #BulkPharmaceuticalExport #WorldwideHealthcare #CancerTreatmentSolutions #MedicalProcurement #LicensedPharmaDistributor #InternationalMedicineTrade #SterileInjectionSupplier #HealthcareImportExport #QualityOncologyMedicines #JamaicaHealthcare #PeruPharmaImport #ParaguayMedicalSupply #IndiaPharmaceuticalExporter #ErnestOncolog 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1